Jay S. Duker, M.D.

Jay S. Duker, M.D.

Contact information

Locations
  • New England Eye Center at Tufts Medical Center
    800 Washington Street Box 450, Boston, MA 02111
    (617) 636-4677
    Map and directions »
Website

Specialty
Ophthalmic Oncologist

Education and Fellowships

Fellowship
Wills Eye Hospital
Residency
Wills Eye Hospital
Medical school
Jefferson Medical College

Current Positions

Director, New England Eye Center
Professor and Chairman
Department of Ophthalmology
Tufts Medical Center
Tufts University School of Medicine


Biography

Jay S. Duker, M.D.
Director, New England Eye Center
Chairman, Department of Ophthalmology, Tufts Medical Center
Professor of Ophthalmology, Tufts University School of Medicine
800 Washington Street, #450, Boston, MA 02111
(617) 636-4677
(617) 636-4866 Fax
jduker@tuftsmedicalcenter.org

EDUCATION

Undergraduate:
1980 A.B. Harvard University, Cambridge, MA, cum laude, general studies
Medical School:
1984 M.D. Jefferson Medical College, Philadelphia, PA, magna cum laude

POSTDOCTORAL TRAINING

Internship and Residency:
1984-1985 Intern, Internal Medicine, Beth Israel Hospital, Boston, MA
1985-1988 Resident, Ophthalmology, Wills Eye Hospital, Philadelphia, PA
1987-1988 Chief Resident, Wills Eye Hospital, Philadelphia, PA

Fellowship:
1988-1990 Fellow, Retina and Vitreous Surgery, Wills Eye Hospital, Philadelphia, PA

LICENSURE AND CERTIFICATION

1985 Pennsylvania (MD 034177E)
1989 Diplomat, American Board of Ophthalmology
1990 Massachusetts (72229)

ACADEMIC APPOINTMENTS

2002 Professor, Ophthalmology, Tufts University School of Medicine, Boston, MA
1992-2002 Assistant Professor, Ophthalmology, Tufts University School of Medicine, Boston, MA
1992 Director, Vitreoretinal Service, New England Eye Center, Boston, MA
1991 Adjunct Clinical Assistant Scientist, Ophthalmology, Eye Research Institute, Boston, MA
1990-1994 Clinical Instructor, Ophthalmology, Harvard Medical School, Boston, MA





HOSPITAL APPOINTMENTS

1990 Associate Staff, Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, MA
1991-2001 Courtesy Staff, Department of Ophthalmology, Newton-Wellesley Hospital, Newton, MA
1991-1992 Associate Ophthalmologist, Tufts-New England Medical Center, Boston, MA
1992 Ophthalmologist, Tufts Medical Center, Boston, MA
1992-2001 Director, Department of Ophthalmology, Vitreoretinal Service,
Tufts-New England Medical Center, Boston, MA
1993 Associate Ophthalmologist, Boston VA Medical Center, Boston, MA
1993 Associate Ophthalmologist, St. Elizabeth’s Medical Center, Boston, MA
1994-2004 Associate Staff Ophthalmologist, Winchester Hospital, Winchester, MA
1996 Associate Staff, SurgiSite Boston, Waltham, MA
1997-2006 Consulting Staff Ophthalmologist, Lawrence General Hospital, Lawrence, MA
1997 Retina Staff, Ophthalmic Consultants of Boston, Boston, MA
2001 Acting Chairman, Department of Ophthalmology,
Tufts-New England Medical Center, Boston, MA
2003 Chairman, Department of Ophthalmology, Tufts-New England Medical Center, Boston, MA


AWARDS AND HONORS

1976 National Merit Finalist
1976 Westinghouse Employees’ Scholarship
1981 March of Dimes Summer Research Grant
1981 CIBA-Geigy Medical Student Award
1981 Who’s Who in American Universities and Colleges
1982 Alpha Omega Alpha, President, Alpha Chapter
1984 Merck Medical Student Award
1988-1989 Heed Ophthalmic Foundation Fellowship
1988 Pennsylvania Lion’s Club Research Grant
1989-1990 Heed/Knapp Ophthalmic Foundation Fellowship
1992 American Academy of Ophthalmology, Honor Award
2003 American Academy of Ophthalmology, Senior Achievement Award
2010 American Society of Retina Specialists, Honor Award
2013 American Society of Retina Specialists, Senior Honor Award
2015 American Academy of Ophthalmology, Life Achievement Honor Award
2015 Brazilian Society of Retina and Vitreous Honor Award




BOARDS and DIRECTORSHIPS

2005 Director, SurgiSite Boston
2010 Director and Founder, Hemera Biosciences
2015 Eleven Biotherapeutics




HOSPITAL, MEDICAL SCHOOL OR UNIVERSITY COMMITTEE ASSIGNMENTS

2001-2002 Medical School Executive Committee
2001-2002 Surgical Executive Committee
2001-2002 NEHCF Finance Committee
2014-2016 Chair, Medical Board


PROFESSIONAL SOCIETIES

1980 American Medical Association
1982 Alpha Omega Alpha
1985 American Academy of Ophthalmology
1986-1990 Pennsylvania Academy of Ophthalmology
1989 Association for Research in Vision and Ophthalmology
1989 Society of Heed Fellows
1989 Wills Eye Hospital Ex-Residents Society
1990 Massachusetts Society of Eye Physicians and Surgeons
1990 Massachusetts Medical Society
1990 FRAME Fluorescein Angiography Club
1992 International Academy of Sports Vision
1993 Vitreous Society
1993 New England Ophthalmology Society
2001 Association of University Professors in Ophthalmology


OFFICE AND COMMITTEE ASSIGNMENTS IN PROFESSIONAL SOCIETIES

1990 Massachusetts Society of Eye Physicians and Surgeons
Member of Executive Board
1991-1992 Bay State Health Care, Advisory Director
1992 Bay State Health Care, Director
1992-1994 Boston Aid to the Blind, Executive Board Member
1995 American Board of Ophthalmology, Oral Board Examiner
1996 American Board of Ophthalmology, Oral Board Examiner
2001 American Board of Ophthalmology, Oral Board Examiner


MAJOR RESEARCH INTERESTS

Drug delivery to the posterior segment
Posterior segment imaging systems


EDITORIAL BOARDS AND ACTIVITY

1994 Editorial Advisory Board, Review of Ophthalmology
1995 Editor, Ophthalmic Surgery and Laser Therapy
1998 Editorial Board, Evidence Based Eye Care
1990 Reviewer, American Journal of Ophthalmology
1991 Reviewer, Archives of Ophthalmology
1992 Reviewer, Investigative Ophthalmology and Visual Science
1993 Reviewer, Lasers in Surgery and Medicine,
1995 Reviewer, Ophthalmic Genetics
1994 Reviewer, New England Journal of Medicine
1993 Reviewer, Ophthalmic Surgery and Lasers
1992 Reviewer, Ophthalmology
1992 Reviewer, Retina
1993 Reviewer, Survey of Ophthalmology
2006 Editorial Advisory Board, Retina Today


VISITING PROFESSORSHIPS

1994 Washington Hospital Centers, Washington, D.C.
1994 University of Indiana Eye Center, Indianapolis, IN
1994 Wills Eye Hospital, Jefferson Medical School, Philadelphia, PA
1994 Temple Eye Center, Temple University, Philadelphia, PA
1996 Bellevue Hospital, New York University, New York, NY
1997 University of Toronto, Toronto, Ontario
1997 Albany Medical School, Albany, NY
1998 Long Island College Hospital, Brooklyn, NY
1999 Wills Eye Hospital, Jefferson Medical School, Philadelphia, PA
2002 Northshore/Long Island Jewish Hospital, Long Island, NY
2003 Columbus EENT Society, Columbus, OH
2011 The Knobloch Visiting Retinal Professor, University of Minnesota and the
Minnesota Academy of Ophthalmology, Minneapolis, MN





CURRENT RESEARCH STUDIES/CLINICAL INVESTIGATOR

Title: R01 EY011289 Novel Diagnostics with Optical Coherence Tomography
Funding Agency: National Institutes of Health/National Eye Institute
Amount:
Period: 06-01-05 to 05-31-10
Role: Co-Investigator

Title: A Phase III, Double-Masked, Multicenter, Randomized, Active Treatment-Controlled Study of the Efficacy and Safety of 0.5mg and 2.0mg Ranibizumab Administered Monthly or on an As-Needed Basis (PRN) in Patients with Subfoveal Neovascular Age-Related Macular Degeneration
Funding Agency: Genentech
Period: 12-11-09 to present
Role: Co-Investigator

Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study
of the Efficacy and Safety of Ranibizumab Injection in Subjects with Clinically
Significant Macular Edema with Center Involvement Secondary to Diabetes Mellitus
Funding Agency: Genentech
Period: 1-27-07 to present
Role: Co-Investigator

Title: A Randomized, Double-Masked, Parallel Group, Multicenter, Dose-Finding
Comparison of the Safety and Efficacy of ASI-001A 0.5 ?g/day and SAI-001B
0.2 ?g/day Flucinolone Acetonide Intravitreal Inserts to Sham Injection in Subjects with Diabetic Macular Edema
Funding Agency: Alimera
Period: 11-01-07 to present
Role: Co-Investigator

Title: Randomized, Prospective, Active Controlled Study of the Epi-Rad Ophthalmic
System for the Treatment of Subfoveal Choroidal Neovascularization Associated
with Wet Age-Related Macular Degeneration
Funding Agency: Neovista
Period: 04-11-08 to present
Role: Co-Investigator

Title: An Open-Label, Multicenter Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects with Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) who have Completed the Treatment Phase of a Genentech-Sponsored Ranibizumab Study
Funding Agency: Genentech
Period: 05-21-09 to present
Role: Co-Investigator

Title: A Phase III, Multicenter, Randomized, Sham Injection-Controlled Study of the
Efficacy and Safety of Ranibizumab Injection Compared with Sham in Subjects
with Macular Edema Secondary to Central Retinal Vein Occlusion
Funding Agency: Genentech
Period: 06-12-07 to present
Role: Co-Investigator

Title: A Randomized, Placebo-Controlled, Double-Masked, Multicenter Trial of
Microplasmin Intravitreal Injection for Non-Surgical Treatment of Focal
Vitreomacular Adhesion
Funding Agency: Thrombogenics
Period: 06-04-09 to present
Role: Co-Investigator



Title: The Impact of Intravitreal Injection on Central Retinal Artery Perfusion Pressure
Funding Agency: Falck Medical
Period: 06-01-2008 to present
Role: Co-Investigator

Title: A Phase II Prospective, Randomized, Mulitcenter, Diabetic Macular Edema Dose Ranging, Comparator Study Evaluating the Efficacy and Safety of PF-04523655 Versus Laser Therapy
Funding Agency: Pfizer
Period: 08-12-08 to present
Role: Co-Investigator

Title: A Two-Year Multicenter, Randomized, Controlled, Masked, Dose-Finding Trial to Assess the Safety and Efficacy of Multiple Intravitreal Injections of AGN 211745 in Patients with Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
Funding Agency: Allergan
Period: 10-27-05 to present
Role: Co-Investigator

ADDITIONAL STUDIES (ie, grants):

Grant Title: Milk Components Inhibit/Acanthamoeba/Induced Cyopathic Effect
Funding Agency: New England Corneal Transplant Research Fund
Amount:
Period: 07-01-08 to 06-30-09
Role: Principal Investigator

Grant Title: Advanced Technologies for Structural and Functional OCT (Optical Coherence Tomography)
Funding Agency: Massachusetts Institute of Technology
Amount:
Period: 12-01-03 to 01-14-10
Role: Principal Investigator

Grant Title: Novel Diagnostics with Optical Coherence Tomography
Agency: Massachusetts Institute of Technology
Amount:
Period: 6-01-05 to 11-30-10
Role: Principal Investigator

Grant Title: Research to Prevent Blindness Challenge Grant
Funding Agency:
Amount:
Period: 07-01-06 to 06-30-10
Role: Principal Investigator

Grant Title: Massachusetts Lions Eye Research Fund
Funding Agency:
Amount:
Period: 09-01-09 to 08-30-10
Role: Principal Investigator


COMPLETED RESEARCH STUDIES

Photodynamic therapy with Purlytin, Phase III trial. Miravant Medical Technologies, Inc.; Investigator, 1998.

Supplemental Oxygen Treatment for Retinopathy of Prematurity Study (STOP-ROP), A Multicenter North American Study; Investigator, 1995-1999.

Ganciclovir Implant for CMV Retinitis. Bausch and Lomb; Principle Investigator, 1994-1996.

A Controlled Trial of Valganciclovir as Induction Therapy for Cytomegalovirus Retinitis. Roche Pharmaceuticals; I

Molecular Antecedents of Brain Damage in Preterm Infants, Elgan Ophthalmology Consultant, Investigator,

Functions of TEA Polyphenols in Human Macula, 2002, Investigator.

A Multicenter Randomized, Masked Controlled Study to Evaluate Retisert, an Intravitreal Flucinolone Implant, in the Treatment of Patients with Diabetic Macular Edema, Protocol FL-005, 2001; Investigator.

A Randomized, Controlled Study on the Efficacy of Sandostatin LAR in the Therapy of Patients with Moderately-Severe Non-Proliferative Diabetic Retinopathy NPDR or Low Risk Proliferative Diabetic Retinopathy, (Novartis) (CCSMS995 0804), 2000, 2001; Investigator.

A Phase II/III Randomized Double Masked Controlled Dose Ranging Multi-Center Comparative Study to Evaluate Safety and Efficacy of EYE001 (Anti-VEGF Pegylated Aptmer) Given Every 6 weeks for 54 weeks in Patients with Exudative Age-Related Macular Degeneration, 2001; Investigator.

The TTT4CNV Clinical Trial: Transpupillary Thermotherapy of Occult Subfoveal Choroidal Neovascular Membranes in Patients with Age-Related Macular Degeneration, New England Eye Center, Boston, MA, 2000, 2001; Co-Investigator.

The Early Treatment of Retinopathy of Prematurity Study (ET-ROP), A Multicenter North American Study, Investigator, 2000, 2001; Investigator.

A Multi-Center, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Dose Finding, Phase II Study PKC412 (50, 100, 150 mg/day) in Patients with Diabetic Macular Edema (CIBA Vision), 2001; Principle Investigator.

PUBLICATIONS

1. Duker JS, Weiss JS, Siber M, Bieber FR, Albert DM. Ocular findings in a new, inheritable syndrome of brain, eye and urogenital abnormalities. Am J Ophthalmol 1985; 99:51-55.

2. Duker JS, Brown GC, Brooks L. Retinal vasculitis in Crohn’s disease. Am J Ophthalmol 1987; 103:664-668.

3. Duker JS, Shields JA, Ross M. Intraocular large cell lymphoma presenting as massive thickening of the uveal tract. Retina 1987; 7:41-45.

4. Duker JS, Belmont J, Bosley Tm. Angioid streaks associated with abetalipoproteinemia (letter). Arch Ophthalmol 1987; 105:1173-1174.

5. Duker JS, Nelson LB. A modification in the frontalis suspension procedure (letter). Am J Ophthalmol 1988; 105:323-324.

6. Duker JS, Brown GC. Iris neovascularization associated with obstruction of the central retinal artery. Ophthalmology 1988; 95:1244-1249.

7. Duker JS, Brown GC, McNamara JA. Proliferative sarcoid retinopathy. Ophthalmology 1988; 95:1680-1686.

8. Duker JS, Belmont JB. Ocular ischemic syndrome secondary to carotid artery dissection (letter). AM J Ophthalmol 1988; 106:750-752.

9. Duker JS, Brown GC. Recovery following acute obstruction of the retinal and choroidal circulations: A case history. Retina 1988; 8:257-260.

10. Duker JS, Brown GC. Neovascularization of the optic disc associated with obstruction of the central retinal artery. Ophthalmology 1989; 96:87-91.

11. Duker JS, Brown GC. The efficacy of panretinal photocoagulation for neovascularization of the iris after central retinal artery obstruction. Ophthalmology 1989; 96:92-95.

12. Duker JS, Shields JA, Eagle RC. Ocular lymphoid hyperplasia. Arch Ophthalmol 1989; 107:446-447.

13. Duker JS, Fischer DH. Occult plastic intraocular foreign body. Ophthalmic Surg 1989; 20:169-170.

14. Duker JS, Sergott RC, Savino PJ, Bosley TM. Optic neuritis with secondary retinal venous stasis. Ophthalmology 1989; 96:475-480.

15. Duker JS, Brown GC. Anterior location of the crossing artery in branch retinal vein
Obstruction. Arch Ophthalmol 1989; 107:998-1000.

16. Duker JS, Ausburger JJ, Shields JA. Non-contiguous local recurrence of posterior uveal melanoma following Co 60 episcleral plaque therapy. Arch Ophthalmol 1989; 107: 1019-1022.

17. Duker, JS, Brown GC, Ballas SK. Peripheral retinal neovascularization associated with hemoglobin C Bo thalassemia (letter). AM J Ophthalmol 1989; 0107:328-329.

18. Clinch TE, Duker JS, Eagle RC, Calhoun J, Augsburger JJ, Fischer DH. Infantile endogenous candida endophthalmitis presenting as a cataract. Surv Ophthalmol 1989; 34:107-112.

19. Duker JS, Federman JL, Schubert H, Talbot CW. Semiconductor diode laser
endophotocoagulation. Ophthalmic Surg 1989; 20:717-719.

20. Duker JS, Belmont JB. Late bacterial endophthalmitis following retinal detachment surgery. Retina 1989; 9:263-266.

21. Levin AV, Zeichner S, Duker JS, Starr SE, Augsburger JJ, Kronwith S. Cytomegalovirus retinitis in an infant with acquired immune deficiency syndrome (AIDS). Pediatrics 1989; 84:683-687.

22. Clinch TE, Duker JS, Eagle RC, Calhoun J, Augsburger JJ, Fischer DH. Infantile endogenous Candida endophthalmitis presenting as a cataract. [case report] Surv Opthalmol. 1989; 34:107-112.

23. Duker JS, Magargal LE, Stubbs GW. Quadrantic venous-stasis retinopathy secondary to an embolic branch retinal artery obstruction. Ophthalmology 1990; 97:167-170.

24. Duker JS, Brown GC, Bosley TM, Colt CA, Reber R. Asymmetric proliferative diabetic retinopathy and carotid artery disease. Ophthalmology 1990; 97:869-874.

25. Duker JS, Cohen MS Brown GC, Sergott RC, McNamara JA. Combined branch retinal artery and central retinal vein obstruction. Retina 1990; 10:105-112.

26. Sivalingam A, Eagle RC, Duker JS, Brown GC, Benson WE, Annesley WH, Federman JL. Visual prognosis correlated with the presence of internal limiting membrane in histopathologic specimens obtained from epiretinal membrane surgery. Ophthalmology 1990; 97:1549-1552.

27. Duker JS, Fischer DH. Herpes virus retinitis. Current Opinion in Infectious Disease. 1990; 3:555-558.

28. Duker JS, Nielsen JC, Eagle RC, Bosley TM, Granadier R, Benson WE. Rapidly progressive acute retinal necrosis (ARN) secondary to herpes simplex virus, type 1. Ophthalmology 1990; 97:1638-1643.

29. Duker JS, Tolentino FI. Retinopathy of prematurity and pediatric retina/vitreous disorders. Current Opinion in Ophthalmol 1990; 1:612-615.

30. Duker JS, Shakin EP. Rapidly progressive acute retinal necrosis with perivenous retinal sparing (letter). AM J Ophthalmol 1991; 111:255-256.

31. Duker JS, Blumenkranz MS. Diagnosis and management of the acute retinal necrosis (ARN) syndrome. Surv Ophthalmol 1991; 35:327-343.

32. Duker JS, Sivalingam AS, Brown GC, Reber R. A prospective study of acute central retinal artery obstruction. The incidence of secondary ocular neovascularization. Arch Ophthalmol 1991; 109:339-342.

33. Bergren RL, Brown GC, Duker JS. Prevalence and association of asteroid hyalosis with systemic disease. AM J Ophthalmol 1991; 111:289-293.

34. Duker JS, Belmont JB, Benson WE, Brooks HL, Brown GC, Federman JL, Fischer DH, Tasman WS. Inadvertent globe perforation during retrobulbar and peribulbar anesthesia: Patient characteristics, surgical management and visual outcome. Ophthalmology 1991; 98:519-526.

35. Duker JS, Nielsen JC, Vander JF, Rosenstein RB, Benson WE. The efficacy of retrobulbar bupivicaine irrigation for post-operative pain following scleral buckling surgery. Ophthalmology 1991; 98:514-518.

36. Vander JF, Duker JS, Benson WE, Brown GC, McNamara JA, Tasman WS, Rosenstein RB. Long term stability and visual outcome after favorable initial response of proliferative diabetic retinopathy to panretinal photocoagulation. Ophthalmology 1991; 98:1575-1579.

37. Duker JS. Review of “Atlas of Ophthalmic Surgery.” Arch Ophthalmol 1991; 190:1657-1658.

38. Duker JS, Tolentino FI. Retinopathy of prematurity and pediatric retina/vitreous disorders. Current Opinion in Ophthalmol 1991; 2:690-695.

39. Regillo CD, Vander JF, Duker JS, Fischer DH, Belmont JB, Kleiner R. Repair of AIDS retinitis related retinal detachments with vitrectomy and silicone oil. Am J Ophthalmol 1992; 113:21-27.

40. Duker JS, Starr Em. Review of “Treatment of Retinopathy of Prematurity” Arch
Ophthalmol 1992; 11:700.

41. Guyer DW, Duker JS, Puliafito CA. Indocyanine green angiography and dye-assisted diode laser photocoagulation. Semin Ophthalmol 1992; 7:172-176.

42. Duker JS. Retinopathy of Prematurity. Current Opinion in Ophthalmol 1992; 3:771-775.

43. Ginsberg R, Duker JS. Perforations of the globe secondary to retro and peri-bulbar anesthesia injections. Semin Ophthalmol 1993; 8:87-95.

44. Ginsberg R, Duker JS. Perforation of the globe as a complication of local ocular anesthesia. Current Opinion in Ophthalmol 1993; 4:50-55.

45. Lozano RD, Duker JS, Jalkh A. Lipid exudate in age related macular degeneration.
Am J Ophthalmol 1993; 116:140-147.

46. Duker JS. Retinal pigment epitheliopathy after macular hole surgery (letter).
Ophthalmology 1993; 100:1604-1605.

47. Brown GC, Duker JS, Lehman R, Eagle RC. Combined central retinal artery-central retinal vein obstruction. Int Ophthalmol 1993; 17:9-17.

48. Morley MG, Duker JS, Zack C. Successful treatment of rapidly progressive outer retinal necrosis in the acquired immunodeficiency syndrome. AM J Ophthalmol 1994; 117:264-265.

49. Margolis TM, Duker JS. Laser treatment of retinal vein occlusion. Ophthalmic Practice 1994; 12:8-13.

50. Reichel E, Puliafito CA, Duker JS, Guyer DR. Indocyanine green dye-enhanced diode laser photocoagulation of poorly defined subfoveal choroidal neovascularization. Ophthalmic Surg 1994; 24:195-201.

51. Keyser BJ, Duker JS, Brown GC, et al. Combined CRVO and cilioretinal artery obstruction associated with prolonged arterial filling. AM J Ophthalmol 1994; 117:308-313.

52. Reichel E, Duker JS. Diabetic Vitrectomy. Current Opinion in Ophthalmol 1994; 5:50-53.

53. Reichel E, Duker JS, Puliafito CA, Hedge TR, Caplan L. Branch retinal artery obstruction caused by a preretinal arterial loop. Neurology 1994; 44:1181-1183.

54. Deegan W, Duker JS. Unifocal choroiditis in primary varicella zoster (chickenpox).
Arch Ophthalmol 1994; 112:735-736.

55. Kim T, Duker JS, Hedges TR. Unilateral retinal angiopathy resembling frosted branch angiitis in a patient with acute lymphoblasic leukemia (letter). AM J Ophthalmol 1994; 117:806-807.

56. Duker JS. A new way to manage macular holes. Rev Ophthalmol 1994; 1:60-63.

57. Duker JS, Wendel R, Patel A, Puliafito CA. Late reopening of macular holes following initially successful vitreous surgery. Ophthalmology 1994; 101:1373-1378.

58. Lin SC, Lin CP, Feld JR, Duker JS, Puliafito CA. The photodynamic occlusion of choroidal vessels using benzoporphyrin derivative. Exp Eye Res 1994; 13:513-522.

59. Puliafito CA, Hee MR, Lin CP, Reichel E, Schuman JS, Duker JS, Izatt JA, Swanson EA, Fujimoto JG. Imaging of macular diseases with optical coherence tomography.
Ophthalmology 1995; 102:217-229.

60. Duker JS. Retrobulbar injections: Standards of care (letter). Surv Ophthalmol 1995; 39:344-345.

61. Morley MG, Duker JS, Ashton P, Robinson MR. Replacing ganciclovir implants.
Ophthalmology 1995; 102:388-392.

62. Avvad F, Reichel E, Margolis TI, Puliafito CP, Duker JS. ICG angiography of well-defined choroidal neovascularization. Ophthalmology 1995; 102:401.405.

63. Park S, Marcus DM, Duker JS, Pesavento RD, Topping TM, Frederick AR, D’Amico D. Posterior segment complication after vitrectomy for macular hole. Ophthalmology 1995; 102:775-781.

64. Hee MR, Puliafito CA, Wong C, Duker JS, Reichel E, Schuman JS, Swanson EA, Fujimoto JG. Optical coherence tomography of macular holes. Am J Ophthalmol 1995; 102; 748-756.

65. Hee MR, Puliafito CA, Wong C, Reichel E, Duker JS, Schuman JS, Swanson EA, Fujimoto JG. Optical coherence tomography of central serous chorioretinopathy. Am J Ophthalmol 1995; 120: 65-74.

66. Cohen RG, Hedges TR, Duker JS. Central retinal artery occlusion in a child with T-cell lymphoma. Am J Ophthalmol 1995; 120:118-120.

67. Duker JS. Review of Color Atlas of Ocular Manifestations of AIDS: Diagnosis and Management. New England J Medical 1995; 328-333.

68. Hee MR, Puliafito CA, Wong C, Duker JS, Reichel E, Rutledge B, Schuman JS, Swanson EA, Fujimoto JG. Quantitative assessment of macular edema with optical coherence tomography (OCT). Arch Ophthalmol 1995; 113:1019-1029.

69. Duker JS, Robinson MR, Anand R, Ashton P. Experience with an 8-month sustained-release intravitreal ganciclovir device for local treatment of Cytomegalovirus (CMV) retinitis associated with the acquired immunodeficiency syndrome (AIDS). Ophth Surg 1995; 26:442-448.

70. Reichel E, Duker JS, Puliafito CA. Indocyanine green (ICG) angiography for choroidal neovascularization obscured by hemorrhage. Ophthalmology 1995; 102:1871-1876.

71. Reichel E, Pollock DA, Duker JS, Puliafito CA. Indocyanine green (ICG) angiography in the detection of marginal persistence and recurrence of choroidal neovascularization. Ophthalmic Surg 1995; 26:513-518.

72. Cano WG, Solares GR, DiPetrillo TA, Meylaerts SA, Lin SC, Zamenhof RG, Saris SC, Duker JS, Goad E, Wazer DE. Toxicity associated with boronophenylalanine and cranial neutron irradiation. Rad One Invest 1995; 3:108-118.

73. Rutledge BK, Puliafito CA, Duker JS, Hee MR, Cox MS. Optical coherence tomography of optic nerve pits. Ophthalmology 1996; 103:1047-1053.

74. Hee M, Baumal CR, Puliafito CA, Duker JS, Reichel E, Wilkins JR, Coker JG, Schuman JS, Swanson EA, Fujimoto JG. Optical coherence tomography of age-related macular degeneration and choroidal neovascularization. Ophthalmology 1996; 103;1260-1270.

75. Duker JS, Davis JL, Chuang E, Keller R, Ashton P. Long Term (>3 Year) Successful Maintenance therapy of Bilateral CMV Retinitis Using Exclusively Local Therapy. Arch Ophthalmol 1996; 114:881-882.

76. Cunningham ET, Short GA, Irvine AR, Duker JS, Margolis TP. AIDS-Associated herpes simplex virus retinitis: clinical description and use of a polymerase chain reaction-based assay as a diagnostic tool. Arch Ophthalmol 1996; 114:834-840.

77. Wilkins JR, Puliafito CA, Hee MR, Duker JS, Reichel E, Coker JG, Schuman JS, Swanson EA, Fujimoto JG. Pre- and Post-operative characteristics of epiretinal membranes assessed with optical coherence tomography. Ophthalmology 1996; 103:2142-2151.

78. Kim V, Duker JS. Ocular Infections in AIDS. Sem Ophthalmol 1996; 11:93-106.

79. Coker JG, Duker JS. Macular Diseases and Optical Coherence Tomography. Current Opinion in Ophthalmology 1996; 7:33-38.

80. The Ganciclovir Implant Study Group. Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant. New England Journal of Medicine 1997; 337:83-90.

81. Haimovici R, Gragoudas ES, Gregor Z Pesavento RD, Mieler WF, Duker JS. Choroidal metastases from renal cell carcinoma. Ophthalmology 1997; 104:1152-1158.

82. Freitag SK, Eagle RC, Shields JS, Duker JS, Font RL. Melanogenic neuroectodermal tumor of the retina (Primary malignant melanoma of the retina). Arch Ophthalmol 1997; 115:1581-1584.

83. Hee MR, Puliafito CA, Duker JS, Reichel E, Coker JG, Wilkins JR, Schuman JS, Swanson EA, Fujimoto JG. Topography of diabetic macular edema with optical coherence tomography. Ophthalmology 1998; 105:360-370.

84. Hatton MP, Duker JS, Reichel E, Morley MG, Puliafito CA, Ashton P. Treatment of relapsed cytomegalovirus retinitis with the sustained release ganciclovir implant. Retina 1998; 18:50-55.

85. Ciulla TA, Rutledge BK, Morley MG, Duker JS. The progressive outer retinal necrosis syndrome: successful treatment with combination antiviral therapy. Ophthalmic Surgery & Lasers. 1998;29(3):198-206.

86. Ip M, Garza-Karren C, Duker JS, Reichel E, Swartz JC, Amirikia A, Puliafito CA. Differentiation of degenerative retinoshisis from retinal detachment using optical coherence tomography. Ophthalmology. 1999;106:600-605.

87. Reichel E, Berrocal AM, Ip M, Kroll A, Desai VD, Duker JS, Puliafito CA. Transpupillary thermotherapy of occult subfoveal choroidal neovascularization in patients with age-related macular degeneration. Ophthalmology 1999; 106:1908-1914.

88. Martin DF, Dunn JP, Davis JL, Duker JS, et al. Use of the ganciclovir implant for the treatment of cytomegalovirus retinitis in the era of potent antiretroviral therapy: recommendations of the International AIDS society - USA panel. Am J Ophthalmol 1999; 127:329-339.

89. Recchia FM, Baumal CR, Sivalingnam A, Kleiner R, Duker JS, Vrabec TR. Endophthalmitis after pediatric strabismus surgery. Arch Ophthalmol. 2000;118:939-944.

90. Martidis A, Duker JS, Puliafito CA. Intravitreal triamcinolone for refractory cystoid macular edema secondary to birdshot retinochoroidopathy. Arch Ophthalmol. 2001;119(9):1380-3.

91. Greenberg PB, Martidis A, Rogers AH, Duker JS, Reichel E. Intravitreal triamcinolone acetonide for macular edema due to central retinal vein occlusion. British Journal of Ophthalmology 2002; 86(2):247-248

92. Ip MS, Baker BJ, Duker JS, Reichel E, Baumal CR, Gangnon R, Puliafito CA. Anatomical Outcomes of Surgery for Idiopathic Macular Hole as Determined by Optical Coherence Tomography. Arch Ophthalmology 2002;120:29-35.

93. Martin DF, Sierra-Madero J, Walmsley S, Wolitz RA, Macey K, Georgiou P, Robinson CA, Stempien MJ and the Valganciclovir Study Group (See Appendix). A Controlled Trial of Valganciclovir as Induction Therapy for Cytomegalovirus Retinitis. New England Journal of Medicine 2002;346:1119-1126.

94. Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E, Baumal C. Intravitreal Triamcinolone for Refractory Diabetic Macular Edema. Ophthalmology 2002; 109 (5):920-7.

95. Rogers AH, Duker JS, Nichols N, Baker BJ. Photodynamic Therapy of Idiopathic and Inflammatory Choroidal Neovascularization in Young Adults. Ophthalmology 2003; 110(7): 1315-20.

96. Campochiaro PA, C99-PKC412-003 Study Group. Reduction of Diabetic Macular Edema by Oral Administration of the Kinase Inhibitor PKC412. IOVS 2004; 45(3): 922-31.

97. Duker JS. Discussion of Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema. Ophthalmology 2004; 111(2): 224-25.

98. Ko TH, Fujimoto JG, Duker JS, Paunescu LA, Drexler W, Baumal CR, Puliafito CA, Reichel E, Rogers AH, Schuman JS. Comparison of Ultrahigh- and Standard- Resolution Optical Coherence Tomography for Imaging Macular Hole Pathology and Repair. Ophthalmology 2004; (111):2033-2043.

99. Chan A, Duker JS, Schuman JS, Fujimoto JG. Stage 0 Macular Holes. Ophthalmology 2004; (111): 2027-2032.

100. Wollstein G, Paunescu LA, Ko TH, Fujimoto JG, Kowalevicz A, Hartl I, Beaton S, Ishikawa H, Mattox CG, Singh O, Duker JS, Drexler W, Schuman JS. Ultrahigh-Resolution Optical Coherence Tomography in Glaucoma. Ophthalmology 2004; 112:229-237.

101. Wojtkowski M, Srinivasan VJ, Ko TH, Fujimoto JG, Kowalczyk, Duker JS. Ultrahigh Resolution, High-Speed, Fourier Domain Optical Coherence Tomography and Methods for Dispersion Compensation. Optics Express 2004; 12:2404-2422.

102. Ko TH, Fujimoto JG, Schuman JS, Paunescu LA, Kowalevicz AM, Hartl I, Drexler W, Wollstein G, Ishikawa H, Duker JS. Comparison of Ultrahigh and Standard Resolution Optical Coherence Tomography for Imaging Macular Pathology. Ophthalmology 2005; 112(11):1922.

103. Wojtkowski M, Srinivasan VJ, Fujimoto JG, Ko TH, Schuman JS, Kowalczyk A, Duker JS. Three-Dimensional Retinal Imaging with High-Speed Ultrahigh-Resolution Optical Coherence Tomography. Ophthalmology 2005; 112(10):1734-46.

104. Witkin AJ, Duker JS. Optical Coherence Tomography of the Vitreomacular Interface in Photodynamic Therapy (Comment). British Journal of Ophthalmology 2005; 89(7):929.

105. Scheufele TA, Witkin AJ, Schocket LS, Rogers AH, Schuman JS, Ko TH, Fujimoto JG, Reichel E, Duker JS. Photoreceptor Atrophy in Acute Posterior Multifocal Placoid Pigment Epitheliopathy Demonstrated by Optical Coherence Tomography. Retina 2005; 25(8):1109-12.

106. Witkin AJ, Duker JS, Ko TH, Fujimoto JG, Schuman JS. Ultrahigh Resolution Optical Coherence Tomography of Birdshot Retinochoroidopathy. British Journal of Ophthalmology Letter 2005; 89(12):1660-1.

107. Chan A, Duker JS. A Standardized Method for Reporting Changes in Macular Thickening Using Optical Coherence Tomography. Arch Ophthalmology 2005; 123:939-943.

108. Chan A, Ko TH, Duker JS. Ultrahigh Resolution Optical Coherence Tomography of Canthaxanthine Retinal Crystals. Ophthalmic Surgery, Lasers & Imaging 2006; 37(2):138-9.

109. Subramanian ML, Truong SN, Rogers AH, Duker JS, Reichel E, Baumal CR. Vitrectomy for Stage 1 Macular Holes Identified by Optical Coherence Tomography. Ophthalmic Surgery, Lasers & Imaging 2006; 37(1):42-6.

110. Schocket LS, Witkin AJ, Fujimoto JG, Ko TH, Schuman JS, Rogers AH, Baumal CR, Reichel E, Duker JS. Ultrahigh-Resolution Optical Coherence Tomography in Patients with Decreased Visual Acuity after Retinal Detachment Repair. Ophthalmology 2006; 113(4):666-72.

111. Witkin AJ, Ko TH, Fujimoto JG, Schuman JS, Baumal CR, Rogers AH, Reichel E, Duker JS. Redefining Lamellar Holes and the Vitreomacular Interface: An Ultrahigh Resolution Optical Coherence Tomography Study. Ophthalmology 2006; 113(3):388-97.

112. Schuman JS, Rogers AH, Duker JS, Reichel E, Baumal CR. Six-Week Outcomes after Pegaptanib. Ophthalmology 2006 Letter; 113(3):501.

113. Paunescu LA, Ko TH, Duker JS, Chan A, Drexler W, Schuman JS, Fujimoto JG. Idiopathic Juxtafoveal Retinal Telangiectasisis: New Findings by Ultrahigh Resolution Optical Coherence Tomography. Ophthalmology 2006; 113(1):48-57.

114. Pieroni CG, Witkin AJ, Ko TH, Fujimoto JG, Chan A, Schuman JS, Ishikawa H, Reichel E, Duker JS. Ultrahigh Resolution Optical Coherence Tomography in Non-Exudative Age Related Macular Degeneration. British Journal of Ophthalmology 2006; 90(2):191-7.

115. Chan A, Duker JS, Ko TH, Fujimoto JG, Schuman JS. Normal Macular Thickness Measurements in Healthy Eyes using Stratus Optical Coherence Tomography. Arch Ophthalmology 2006; 124(2):193-8.

116. Chan A, Duker JS, Ko TH, Schuman JS, Fujimoto JG. Ultrahigh Resolution Optical Coherence Tomography of Retinal Pigment Epithelial Tear Following Blunt Trauma. Arch Ophthalmology 2006; 124(2):281-3.

117. Witkin AJ, Rogers AH, Ko TH, Fujimoto JG, Schuman JS, Duker JS. Optical Coherence Tomography Demonstration of Macular Infarction in Sickle Cell Retinopathy. Arch Ophthalmology 2006; 124:746-747.

118. Ko TH, Witkin AJ, Fujimoto JG, Chan A, Rogers AH, Baumal CR, Schuman JS, Drexler W, Reichel E, Duker JS. Ultrahigh-Resolution Optical Coherence Tomography of Surgically Closed Macular Holes. Arch Ophthalmology 2006; 124:1-10.

119. Srinivasan VJ, Wojtkowski M, Fujimoto JG, Duker JS. In vivo measurement of retinal physiology with high-speed ultrahigh-resolution optical coherence tomography. Optics Letters 2006: 31: 2308-2310.

120. Kagemann L, Wollstein G, Ishikawa H, Gabriele ML, Srinivasan VJ, Wojtkowski M, Duker JS, Fujimoto JG, Schuman JS. Persistence of Cloquet’s Canal in Normal Healthy Eyes. AJO 2006: 862-864.

121. Srinivasan VJ, Ko TH, Wojtkowski M, Carvalho M, Clermon A, Bursell SE, Song QH, Lem J, Duker JS, Schuman JS, Fujimoto JG. Noninvasive Volumetric Imaging and Morphometry of the Rodent Retina with High-Speed, Ultrahigh-Resolution Optical Coherence Tomography. IOVS 2006: 47: 5522-5528.

122. Srinivasan VJ, Wojtkowski M, Witkin AJ, Duker JS, Ko TH, Carvalho M, Schuman JS, Kowalczyk A, Fujimoto JG. High-Definition and 3-dimentional Imaging of Macular Pathologies with High-speed Ultrahigh-Resolution Optical Coherence Tomography. Ophthalmology 2006: 113: 2054-2065.

123. Witkin AJ, Ko TH, Fujimoto JG, Chan A, Drexler W, Schuman JS, Reichel E, Duker JS. Ultra-High Resolution Optical Coherence Tomography Assessment of Photoreceptors in Retinitis Pigmentosa and Related Diseases. AJO 2006: 142: 945-952.

124. Chen RW, Duker JS. Interpretation of OCT: Pearls in Age-Related Macular Degeneration. Highlights of Ophthalmology 2006: 34: 11-14.

125. Kahook MY, Noecker RJ, Ishikawa H, Wollstein G, Kagemann L, Wojtkowski M, Duker JS, Srinivasan VJ, Fujimoto JG, Schuman JS. Peripapillary Schisis in Glaucoma Patients with Narrow Angles and Increased Intraocular Pressure. AJO 2007: 143: 697.

126. Gabriele ML, Ishikawa H, Wollstein G, Bilonick RA, Kagemann L, Wojtkowski M, Srinivasan VJ, Fujimoto JG, Duker JS, Schuman JS. Peripapillary Nerve Fiber Layer Thickness Profile Determined with High Speed, Ultrahigh Resolution Optical Coherence Tomography High-Density Scanning. IOVS July 2007: 48: 3154-3160.

127. Yoon MK, Chen RW, Hedges III TR, Srinivasan VJ, Gorczynska I, Fujimoto JG, Wojtkowski M, Schuman JS, Duker JS. High-Speed, Ultrahigh Resolution Optical Coherence Tomography of the Retina in Hunter Syndrome. OSLI September/October 2007: 38, 5: 423-428.

128. Manassakorn A, Ishikawa H, Kim JS, Wollstein G, Bilonick RA, Kagemann L, Gabriele ML, Sung KR, Mumcuoglu T, Duker JS, Fujimoto JG, Schuman JS. Comparison of Optic Disc Margin Identified by Color Disc Photography and High-Speed Ultrahigh-Resolution Optical Coherence Tomography. Arch Ophthalmol. 126(1):58-64, Jan 2008.

129. Srinivasan VJ, Monson BK, Wojtkowski M, Bilonick RA, Gorczynska I, Chen R, Duker JS, Schuman JS, Fujimoto JG. Characterization of outer retinal morphology with high-speed, ultrahigh-resolution optical coherence tomography. IOVS. 49(4):1571-9, Apr 2008.

130. Mumcuoglu T, Wollstein G, Wojtkowski M, Kagemann L, Ishikawa H, Gabriele ML, Srinivasan V, Fujimoto JG, Duker JS, Schuman JS. Improved Visualization of Glaucomatous Retinal Damage Using High-speed Ultrahigh-Resolution Optical Coherence Tomography. Ophthalmology. 115(5):782-789.e2, May 2008.

131. Gabriele ML, Ishikawa H, Wollstein G, Bilonick RA, Townsend KA, Kagemann L, Wojtkowski M, Srinivasan VJ, Fujimoto JG, Duker JS, Schuman JS. Optical coherence tomography scan circle location and mean retinal nerve fiver layer measurement variability. IOVS. 49(6):2315-21, Jun 2008.

132. Gorczynska I, Srinivasan VJ, Vuong LN, Chen RWS, Liu JJ, Reichel E, Wojtkowski M, Schuman JSS, Duker JS, Fujimoto JG. Projection OCT fundus imaging for visualizing outer retinal pathology in non-exudative age related macular degeneration. BJO Jul 2008: 10.1136/bjo.2007.136101.

133. Li L, Duker JS, Yoshida Y, Niki E, Rasmussen H, Russell RM, Yeum K-J. Oxidative stress and antioxidant status in older adults with early cataract. Eye (Nature) Sept 2008, 1-5.

134. Srinivasan VJ, Adler DC, Chen Y, Gorczynska I, Huber R, Duker JS, Schuman JS, Fujimoto JG. Ultrahigh-Speed Optical Coherence Tomography for Three-Dimensional and En Face Imaging of the Retina and Optic Nerve Head. IOVS Nov 2008: 49, 11: 5103-5110.

135. Wiegand TW, Rogers AH, McCabe F, Reichel E, Duker JS. Intravitreal bevacizumab (Avastin) treatment of choroidal neovascularization in patients with angioid streaks. BJO. 93(1):47-51, Jan 2009.

136. Chen Y, Vuong LN, Liu JJ, Ho J, Srinivasan VJ, Gorczynska I, Witkin AJ, Duker JS, Schuman JS, Fujimoto JG. Three-dimensional ultrahigh resolution optical coherence tomography imaging of age-related macular degeneration. Optics Express. 17(5):4046-60, Mar 2, 2009.

137. Srinivasan VJ, Chen Y, Duker JS, Fujimoto JG. In vivo functional imaging of intrinsic scattering changes in the human retina with high-speed ultrahigh resolution OCT. Optics Express. 17(5):3861-77, Mar 2, 2009.

138. Ishikawa H, Kim J, Friberg TR, Wollstein G, Kagemann L, Gabriele ML, Townsend KA, Sung KR, Duker JS, Fujimoto JG, Schuman JS. Three-Dimensional Optical Coherence Tomography (3D-OCT) Image Enhancement with Segmentation-Free Contour Modeling C-Mode. IOVS Mar 2009: 50, 3: 1344-1349.

139. Kaluzny JJ, Wojtkowski M, Sikorski BL, Szkulmowski M, Szkulmowska A, Bajrasewski T, Fujimoto JG, Duker JS, Schuman JS, Kowalczyk A. Analysis of the Outer Retina Reconstructed by High-Resolution, Three-Dimensional Spectral Domain Optical Coherence Tomography. OSLI Mar/Apr 2009: 40, 2: 102-108.

140. Gorczynska I, Srinivasan VJ, Vuong LN, Chen RWS, Liu JJ, Reichel E, Wojtkowski M, Schuman JS, Duker JS, Fujimoto JG. Projection OCT fundus imaging for visualizing outer retinal pathology in non-exudative age-related macular degeneration. BJO. 93(5):603-9, May 2009.

141. Witkin AJ, Vuong LN, Srinivasan VJ, Gorczynska I, Reichel E, Baumal CR, Rogers AH, Schuman JS, Fujimoto JG, Duker JS. High-speed ultrahigh resolution optical coherence tomography before and after ranibizumab for age-related macular degeneration. Ophthalmology. 116(5):956-63, May 2009.

142. Yoon SJ, Rhee DY, Marx JL, Blaha GR, Rogers AH, Baumal CR, Reichel E, Duker JS. Anatomic and Visual Outcomes of Noninfectious Endophthalmitis after Intravitreal Triamcinolone. AJO Jun 2009: 147, 6:1031-1036.

143. Kim JS, Ishikawa H, Sung KR, Xu J, Wollstein G, Bilonick RA, Gabriele ML, Kagemann L, Duker JS, Fujimoto JG, Schuman JS. Retinal nerve fiber layer thickness measurement reproducibility improved with spectral domain optical coherence tomography. BJO. 93(8): 1057-63. Aug 2009.

144. Ho J, Sull AC, Vuong LN, Chen U, Liu JJ, Fujimoto JG, Schuman JS, Duker JS. Assessment of artifacts and reproducibility across spectral- and time-domain optical coherence tomography devices. Ophthalmology. 116(10):1960-70, Oct 2009.

145. Chieh JJ, Rogers AH, Wiegand TW, Baumal CR, Reichel E, Duker JS. Short-Term Safety of 23-Gauge Single-Step Transconjunctival Vitrectomy Surgery. Retina. 29(10):1486-1490, Nov/Dec 2009.

146. Sull AC, Vuong LN, Price LL, Srinivasan VJ, Gorczynska I, Fujimoto JF, Schuman JS, Duker JS. Comparison of Spectral/Fourier Domain Optical Coherence Tomography Instruments for Assessment of Normal Macular Thickness. Retina. 2010 February; 30(2): 235.

147. Jun JJ, Duker JS, Baumal CR, McCabe F, Reichel E, Rogers AH, Seddon JM, Tolentino FI.
Cystoid Macular Edema without Macular Thickening – A Retrospective Optical Coherence Tomographic Study. Retina. June 2010;30(6):917-923.

148. Witkin AJ, Castro LC, Reichel E, Rogers AH, Baumal CR, Duker JS. Anatomic and Visual
Outcomes of Vitrectomy for Lamellar Macular Holes. OSLI. July/August 2010;41(4):418-424.

149. Witkin AJ, Patron ME, Castro LC, Reichel E, Rogers AH, Baumal CR, Duker JS. Anatomic
and Visual Outcomes of Vitrectomy for Vitreomacular Traction Syndrome. OSLI. July/August 2010;41(4):425-431.

150. Manjunath V, Taha M, Fujimoto JG, Duker JS. Choroidal Thickness in Normal Eyes
Measured Using Cirrus HD Optical Coherence Tomography. AJO. September 2010;150(3): 325-329.

151. Laver NV, McLaughlin ME, Duker JS. Ocular Melanoma. Arch of Pathology & Laboratory Medicine. December 2010;134(12):1778-1784.

152. Wollstein G, Kagemann L, Bilonick RA, Ishikawa H, Folio LS, Gabriele ML, Ungar AK,
Duker JS, Fujimoto JG, Schuman JS. Retinal nerve fiber layer and visual function loss in
glaucoma: the tipping point. BJO. January 2011;96(1)47-52.

153. Bradley JL, Shah SP, Manjunath V, Fujimoto JF, Duker JS, Reichel E. Ultra-high-resolution Optical Coherence Tomographic Findings in Commotio Retinae. Archives of Ophthalmology. January 2011;129(1):107-8.

154. Manjunath V, Taha M, Fujimoto JG, Duker JS. Posterior Lattice Degeneration Characterized By Spectral Domain Optical Coherence Tomography. Retina. March 2011;31:492-496.

155. Manjunath V, Shah H, Fujimoto JG, Duker JS. Analysis of peripapillary atrophy using spectral domain optical coherence tomography. Ophthalmology. March 2011;118(3):531-6.

156. Ho J, Witkin AJ, Liu J, Chen Y, Fujimoto JG, Schuman JS, Duker JS. Documentation of Intraretinal Retinal Pigment Epithelium Migration via High-Speed Ultrahigh-Resolution Optical Coherence Tomography. Ophthalmology. April 2011;118:687-693.

157. Baumann B, Potsaid B, Kraus MF, Liu JJ, Huang D, Hornegger J, Cable AE, Duker JS, Fujimoto JG. Total retinal blood flow measurement with ultrahigh speed swept source/Fourier domain OCT. Biomedical Optics Express. May 2011;2(6):1539-1552.

158. Manjunath V, Goren J, Fujimoto JG, Duker JS. Analysis of Choroidal Thickness in Age-Related Macular Degeneration Using Spectral-Domain Optical Coherence Tomography. AJO. June 2011;152(4):663-668.

159. Regatieri CV, Branchini L, Duker JS. The Role of Spectral-Domain OCT in the Diagnosis and Management of Neovascular Age-Related Macular Degeneration. Ophthalmic Surgery, Lasers & Imaging. July 2011; 42 Suppl:S56-66 (Review).

160. Leonard KL, Gagne NL, Mignano JE, Duker JS, Bannon EA, Rivard MJ. A 17-year retrospective study of institutional results for eye plaque brachytherapy of uveal melanoma using (125)I, (103)Pd, and (131)Cs and historical perspective. Brachytherapy. Jul-Aug 2011;10(4):331-9.

161. Ho J, Branchini L, Regatieri C, Krishnan C, Fujimoto JG, Duker JS. Analysis of Normal Peripapillary Choroidal Thickness via Spectral Domain Optical Coherence Tomography. Ophthalmology. October 2011;118(10):2001-7.

162. Manjunath V, Goren J, Fujimoto JG, Duker JS. Analysis of choroidal thickness in age-related
macular degeneration using spectral-domain OCT. American Journal of Ophthalmology.
October 2011;152(4):663-8.

163. Chan MD, Melhus CS, Mignano JE, Do-Dai D, Duker JS, Yao KC. Analysis of visual
toxicity after gamma knife radiosurgery for treatment of choroidal melanoma:
identification of multiple targets and mechanisms of toxicity. American Journal of
Clinical Oncology. October 2011;34(5):517-23.

164. Goren JF, Shah SP, Janzen GP, Gross NE, Duker JS. Diffuse retinal pigment epithelial disease
in an adult with cystic fibrosis. Ophthalmic Surgery, Lasers & Imaging. 2011;42 Online:e56-
8.

165. Liu YY, Ishikawa H, Chen M, Wollstein G, Duker JS, Fujimoto JG, Schuman JS, Rehg JM.
Computerized macular pathology diagnosis in spectral domain optical coherence tomography
scans based on multiscale texture and shape features. Investigative Ophthalmology &
Visual Science. 2011;52(11):8316-22.

166. Branchini L, Regatieri CV, Flores-Moreno I, Baumann B, Fujimoto JG, Duker JS. Reproducibility of Choroidal Thickness Measurements Across Three Spectral Domain Optical Coherence Tomography Systems. Ophthalmology. Jan 2012;119(1):119-23.

167. Wollstein G, Kagemann L, Bilonick RA, Ishikawa H, Folio LS, Gabriele ML, Ungar AK,
Duker JS, Fujimoto JG, Schuman JS. Retinal nerve fiber layer and visual function loss
In glaucoma: the tipping point. British Journal of Ophthalmology. Jan 2012;96(1):47-52.

168. Gagne NL, Leonard KL, Huber KE, Mignano JE, Duker JS, Laver NV, Rivard MJ. BEDVH-A method for evaluating biologically effective dose volume histograms: Application to eye plaque brachytherapy implants. Medical Physics. Feb 2012;39(2):976-983.

169. Regatieri CS, Branchini L, Carmody J, Fujimoto JG, Duker JS. Choroidal Thickness in Patients with Diabetic Retinopathy Analyzed by Spectral-Domain OCT. Retina. Mar 2012;32(3):563-8.

170. Baumann B, Choi W, Potsaid B, Huang D, Duker JS, Fujimoto JG. Swept source/Fourier domain polarization sensitive optical coherence tomography with a passive polarization delay unit. Optics Express. April 23, 2012;20(9):10218-30.

171. Choi W, Baumann B, Liu JJ, Clermont AC, Feener EP, Duker JS, Fujimoto JG. Measurement of pulsatile total blood flow in the human and rat retina with ultrahigh speed spectral/Fourier domain OCT. Biomedical Optics Express. May 1, 2012;3(5):1047-61.

172. Regatieri CV, Branchini L, Fujimoto JG, Duker JS. Choroidal imaging using spectral-domain optical coherence tomography. Retina. May 2012; 32(5):865-76. (Review)

173. Lehmann S, Guadagni F, Moore H, Ashton G, Barnes M, Benson E, Clements J, Koppandi I, Coppola D, Demiroglu SY, DeSouza Y, De Wilde A, Duker JS, Eliason J, Glazer B, Harding K, Jeon JP, Kessler J, Kokkat T, Nanni U, Shea K, Skubitz A, Somiari S, Tybring G, Gunter E, Betsou International Society for Biological and Environmental Repositories Isber Working Group on Biospecimen Science F. Biopreservation and Biobanking. Aug 2012;10(4):366-74.

174. Renz J, Fein JG, Vora RA, Woodcome Jr. H, Reichel E, Duker JS. Unilateral Retinal Pigment Epithelium Dysgenesis May Be a Bilateral Disease. Arch Ophthalmology. Oct 2012; 130(10):1340-1342.

175. Reisner AA, Vora RA, Goldman DR, Duker JS. Myopic Schisis with Scrolled Posterior Hyaloid. Arch Ophthalmology. Oct 2012;130:1357.

176. Alwassia AA, Adhi M, Duker JS. Bilateral Simultaneous Stage 1 Macular Hole. OSLI. 2012;43 Online:e99-e103.

177. Regatieri CV, Alwassia AA, Zhang JY, Vora R, Duker JS. Use of Optical Coherence Tomography in the Diagnosis and Management of Uveitis. International Ophthalmology Clinics. 2012;52(4):33-43.

178. Liang MC, Vora RA, Duker JS, Reichel E. Solid-Appearing Retinal Cysts in Diabetic Macular Edema: A Novel Optical Coherence Tomography Finding. Retinal Cases & Brief Reports. 2013;7(3):255-258.

179. Choi W, Potsaid B, Jayaraman V, Baumann B, Grulkowski I, Liu JJ, Lu CD, Cable AE, Huang D, Duker JS, Fujimoto JG. Phase-sensitive swept-source optical coherence tomography imaging of the human retina with a vertical cavity surface-emitting laser light source. Opt. Lett. 38, 338-340. 2013.

180. Adhi M, Duker JS. Optical Coherence Tomography-Current and Future Applications. Curr Opin Ophthalmol. 24(3):213-221.

181. Alwassia AA, Adhi M, Zhang JY, Regatieri CV, Al-Quthami A, Salem D, Fujimoto JG, Duker JS. Exercise-Induced Acute Changes in Systolic Blood Pressure do not Alter Choroidal Thickness as Measured by a Portable Spectral-Domain Optical Coherence Tomography Device. Retina. Jan 2013;33(1):165-5.

182. Adhi M, Bryant JS, Alwassia AA, Chen C, Duker JS. De Novo Appearance of a Choroidal Osteoma in an Eye with Previous Branch Retinal Vein Occlusion. OSLI Retina. Jan/Feb 2013;44(1):77-80.

183. Choi W, Potsaid B, Jayaraman V, Baumann B, Grulkowski I, Liu JJ, Lu CD, Cable AE, Huang D, Duker JS, Fujimoto JG. Phase-Sensitive Swept-Source Optical Coherence Tomography Imaging of the Human Retina with a Vertical Cavity Surface-Emitting Laser Light Source. Optic Letters. Feb 2013;38(3):338-40.

184. Shah SP, Manjunath V, Rogers AH, Baumal CR, Reichel E, Duker JS. Optical Coherence Tomography-Guided Facedown Positioning for Macular Hole Surgery. Retina. Feb 2013;33(2):356-62.

185. Flores-Moreno I, Lugo F, Duker JS, Ruiz-Moreno JM. The Relationship Between Axial Length and Choroidal Thickness in Eyes with High Myopia. AJO. Feb 2013;155(2):314-319.

186. Alwassia AA, Adhi M, Duker JS. Bilateral Simultaneous Central Serous Chorioretinopathy in a Teenage Girl with Systemic Arterial Hypertension. International Ophthalmology. Feb 2013;33(1):79-82

187. Cho H, Alwassia AA, Regiatieri CV, Zhang JY, Baumal CR, Waheed NK, Duker JS. Retinal Neovascularization Secondary to Proliferative Diabetic Retinopathy Characterized by Spectral Domain OCT. Retina. Mar 2013;33(3):542-7.

188. Branchini LA, Regatieri C, Adhi M, Flores-Moreno I, Manjunath V, Fujimoto JG, Duker JS. Effect of Intravitreous Anti-Vascular Endothelial Growth Factor on Choroidal Thickness in Neovascular Age-Related Macular Degeneration using Spectral-Domain Optical Coherence Tomography. JAMA Ophthalmology. May 2013;131(5):693-4.

189. Adhi, M, Duker JS. Optical Coherence Tomography – Current and Future Applications. Current Opinion in Ophthalmology. May 2013;24(3):213-21.

190. Adhi M, Regatieri CV, Branchini LA, Zhang JY, Alwassia AA, Duker JS. Analysis of the Morphology and Vascular Layers of the Choroid in Retinitis Pigmentosa Using Spectral-Domain OCT. OSLI Retina. May/June 2013; 44(3):252-259.

191. Chen JJ, Vora RA, Arrigg P, Duker JS, Keane PA, Sadda SR, Yang SS. Diagnostic and Therapeutic Challenges. Retina. Jun 2013;33(6):1273-8.

192. Liang MC, Vora RA, Duker JS, Spaide RF. Diagnostic and Therapeutic Challenges. Retina. Jul/Aug 2013;33(7):1471-4.

193. Adhi M, Brewer E, Waheed NK, Duker JS. Analysis of Morphological Features and Vascular Layers of Choroid in Diabetic Retinopathy Using Spectral-Domain Optical Coherence Tomograpy. Jama Ophthalmology Online. Aug 2013; E1-E8.

194. Flores-Moreno I, Ruiz-Medrano J, Duker JS, Ruiz-Moreno JM. The Relationship Between Retinal and Choroidal Thickness and Visual Acuity in High Myopic Eyes. BJO. Aug 2013;97(8):1010-3.

195. Branchini LA, Adhi M, Regatieri CV, Nandakumar N, Liu JJ, Laver N, Fujimoto JG, Duker JS. Analysis of Choroidal Morphologic Features and Vasculature in Healthy Eyes Using Spectral-Domain Optical Coherence Tomography. Ophthalmology. September 2013; 120(9):1901-1908.

196. Goldman DR, Duker JS. Spontaneous Improvement of Macular Traction Retinal Detachment Associated with Myopic Macular Schisis. Ophthalmic Surg Lasers Imaging Retina. Sep/Oct 2013; 497-498.

197. Adhi M, Brewer E, Waheed NK, Duker JS. Analysis of Morphological Features and Vascular Layers of Choroid in Diabetic Retinopathy Using Spectral-Domain Optical Coherence Tomography. JAMA Ophthalmology. Oct 2013;131(10):1267-74.

198. Copete S, Flores-Moreno I, Montero JA, Duker JS, Ruiz-Moreno, JM. Direct Comparison of Spectral-Domain and Swept-Source OCT in the Measurement of Choroidal Thickness in Normal Eyes. BJO. Nov 2013; 0:1-5.

199. Grulkowski I, Liu JJ, Zhang JY, Potsaid B, Jayaraman V, Cable AE, Duker JS, Fujimoto JG. Reproducibility of a Long-Range Swept-Source Optical Coherence Tomography Ocular Biometry System and Comparison with Clinical Biometers. Ophthalmology. Nov 2013; 120(11):2184-2190.

200. Kadasi LM, Adhi M, Liang MC, Duker JS. Retinal Pigment Epithelial Detachment with Disgorgement in Age-Related Macular Degeneration Observed with OCT. OSLI Retina. Nov/Dec 2013;44(6 Suppl):S30-2.

201. Adhi M, Liu JJ, Qavi AH, Grulkowski I, Fujimoto JG, Duker JS. Enhanced Visualization of the Choroido-Scleral Interface using Swept-Source OCT. OSLI Retina. Nov/Dec 2013;44(6 Suppl):S40-2.

202. Duker JS, Moshfeghi AA. Ocriplasmin: A Medical or Surgical Therapy? Retina. Nov/Dec 2013;33(10):2001-2.

203. Stalmans P, Duker JS, Kaiser PK, Heier JS, Dugel PU, Gandorfer A, Sebag J, Haller JA. OCT-Based Interpretation of the Vitreomacular Interface and Indications for Pharmacologic Vitreolysis. Retina. Nov/Dec 2013; 33(10):2003-11.

204. Duker JS, Kaiser PK, Bider S, de Smet MD, Gaudric A, Reichel E, Sadda SR, Sebag J, Spaide RF, Stalmans P. The International Vitreomacular Traction Study Group Classification of Vitreomacular Adhesion, Traction and Macular Hole. Ophthalmology. Dec 2013; 120(12):2611-2619.

205. Lu CD, Kraus MF, Potsaid B, Liu JJ, Choi W, Jayaraman V, Cable AE, Hornegger J, Duker JS, Fujimoto JG. Handheld Ultrahigh Speed Swept Source Optical Coherence Tomography Instrument Using MEMS Scanning Mirror. Biomedical Optics Express. Dec 2013;5(1):293-311.

206. Adhi M, Alwassia AA, Duker JS. Analysis of Choroidal Thickness in Eyes Treated with Focal Laser Photocoagulation Using SD-OCT. Canadian Journal of Ophthalmology. Dec 2013;48(6):535-8.

207. Duker JS, Kaiser PK, Binder S, de Smet MD, Gaudric A, Reichel E, Sadda SR, Sebag J, Spaide RF, Stalmans P. The International Vitreomacular Traction Study Group Classification of Vitreomacular Adhesion, Traction, and Macular Hole. Ophthalmology. Dec 2013;120(12):2611-9.

208. Gobuty M, Adhi M, Duker JS. Central Serous Chorioretinopathy in a 91-Year Old Woman. BJO. Dec 2013;97(12):1607-8.

209. Ophthalmic Oncology Task Force. The American Brachytherapy Society Consensus Guidelines for Plaque Brachytherapy of Uveal Melanoma and Retinoblastoma. Elsevier-Article in Press.

210. Choi W, Mohler KJ, Potsaid B, Lu CD, Liu JJ, Jayaraman V, Cable AE, Duker JS, Huber R, Fujimoto JG. Choriocapillaris and Choroidal Microvasculature Imaging with Ultrahigh Speed OCT Angiography. PloS ONE. 2013;8(12):e81499.

211. Goldman DR, Barnes AC, Vora RA, Duker JS. Leaking Choroidal Nevus Treatment with Focal Laser Photocoagulation. Retinal Cases and Brief Reports. January 2014;8(2):135-137.

212. Bhavsar KV, Branchini LA, Shah H, Regatieri CV, Duker JS. Choroidal Thickness in Retinal Pigment Epithelial Tear as Measured by Spectral Domain Optical Coherence Tomography. Retina. January 2014;34(1):63-8.

213. Flores-Moreno I, Ruiz-Medrano J, Duker JS, Ruiz-Moreno JM. The Relationship Between Retinal and Choroidal Thickness and Visual Acuity in Highly Myopic Eyes. BJO. Jan 2014;98(1):143-4.

214. Fein JG, Branchini LA, Manjunath V, Regatieri CV, Fujimoto JG, Duker JS. Analysis of Short-Term Change in Subfoveal Choroidal Thickness in Eyes with Age-Related Macular Degeneration using Optical Coherence Tomography. OSLI Retina. Jan/Feb 2014;45(1):32-7.

215. Adhi M, Lau M, Liang MC, Waheed NK, Duker JS. Analysis of the Thickness and Vascular Layers of the Choroid in Eyes with Geographic Atrophy using Spectral-Domain Optical Coherence Tomography. Retina. Feb 2014;34(2):306-12.

216. Lally DR, Duker JS. Foveal Injury from a Red Laser Pointer. JAMA Ophthalmology. Mar 2014;132(3):297.

217. Ferrara D, Mohler KJ, Waheed NK, Adhi M, Liu JJ, Grulkowski I, Kraus MF, Baumal CR, Hornegger J, Fujimoto JG, Duker JS. En Face Enhanced-Depth Swept-Source Optical Coherence Tomography Features of Chronic Central Serous Chorioretinopathy. Ophthalmology. Mar 2014;121(3):719-26.

218. Copete S, Flores-Moreno I, Montero JA, Duker JS, Ruiz-Moreno JM. Direct Comparison of Spectral-Domain and Swept-Source OCT in the Measurement of Choroidal Thickness in Normal Eyes. BJO. Mar 2014;98(3):334-8.

219. Joye RP, Williams LB, Chan MD, Witkin AJ, Schirmer CM, Mignano JE, Wazer DE, Yao KC, Wu JK, Duker JS. Local Control and Results of Leksell Gamma Knife Therapy for the Treatment of Uveal Melanoma. OSLI Retina. Mar/Apr 2014;45(2):125-31.

220. Lee GD, Chen VM, Barnes AC, Goldman DR, Duker JS. Retinal Telangiectasias Detected During a Vision Screening Examination in a Child with Hearing Loss Led to the Diagnosis of Facioscapulohumeral Muscular Dystrophy. Journal of Aapos: American Association for Pediatric Ophthalmology & Strabismus. Jun 2014;18(3):303-5.

221. Barnes AC, Goldman DR, Laver NV, Duker JS. Congenital Simple Hamartoma of the Retinal Pigment Epithelium: Clinical, Optical Coherence Tomography, and Histopathological Correlation. Eye. Jun 2014;28(6):765-6.

222. Ruiz-Medrano J; Flores-Moreno I, Pena-Gracia P, Montero JA, Duker JS, Ruiz-Moreno JM. Macular Choroidal Thickness Profile in a Healthy Population Measured by Swept-Source Optical Coherence Tomography. IOVS. Jun 2014;55(6):3532-42.

223. Allred EN, Capone A Jr, Fraioli A, Dammann O, Droste P, Duker JS, Gise R, Kuban K, Leviton A, O’Shea TM, Paneth N, Petersen R, Trese M, Stoessel K, Vanderveen D, Wallace DK, Weaver G. Retinopathy of Prematurity and Brain Damage in the Very Preterm Newborn. Journal of Aapos: American Association for Pediatric Ophthalmology & Strabismus. Jun 2014;18(3):241-7.

224. Adhi M, Liu JJ, Qavi AH, Grulkowski I, Lu CD, Mohler KJ, Ferrara D, Kraus MF, Baumal CR, Witkin AJ, Waheed NK, Hornegger J, Fujimoto JG, Duker JS. Choroidal Analysis in Healthy Eyes using Swept-Source Optical Coherence Tomography Compared to Spectral Domain Optical Coherence Tomography. AJO. Jun 2014;157(6):1272-1281.

225. Goldberg RA, Waheed NK, Duker JS. Optical Coherence Tomography in the Preoperative and Postoperative Management of Macular Hole and Epiretinal Membrane. BJO. Jul 2014;98Suppl 2:ii20-3.

226. Ruiz-Medrano J, Flores-Moreno I, Pena-Garcia P, Montero JA, Duker JS, Ruiz-Moreno JM. Choroidal Thickness and Axial Length. IOVS. Aug 2014;55(8):5055.

227. Gornik KR, Pirie CG, Duker JS, Boudrieau RJ. Canine Multifocal Retinopathy Caused by a BEST1 Mutation in a Boerboel. Veterinary Ophthalmology. Sep 2014;17(5):368-72.

228. Alasil T, Adhi M, Liu JJ, Fujimoto JG, Duker JS, Baumal CR. Spectral-Domain and Swept-Source OCT Imaging of Asteroid Hyalosis: A Case Report. OSLI Retina. Sept/Oct 2014;45:459-461.

229. Lally DR, Duker JS, Mignano JE, Martin S, Witkin AJ. Regression of Choroidal Metastasis from Breast Carcinoma Treated with Gamma Knife Radiosurgery. JAMA Ophthalmology. October 2014;132(10):1248-1249.

230. Adhi M, Read SP, Liu JJ, Fujimoto JG, Duker JS. High-Speed Ultrahigh-Resolution OCT of Bruch’s Membrane in Membranoproliferative Glomerulonephritis Type 2. OSLI Retina. Nov/Dec 2014;45(6):614-7.

231. Moult E, Choi W, Waheed NK, Adhi M, Lee B, Lu CD, Jayaraman V, Potsaid B, Rosenfeld PJ, Duker JS, Fujimoto JG. Ultrahigh-Speed Swept-Source OCT Angiography in Exudative AMD. OSLI Retina. Nov/Dec 2014;45(6):496-505.

232. Lee GD, Baumal CR, Lally D, Pitcher JD, Vander J, Duker JS. Retinal Injury after Inadvertent Handheld Laser Exposure. Retina. Dec 2014;34(12):2388-96.

233. Goldman DR, Barnes AC, Vora RA, Duker JS. Leaking Choroidal Nevus Treated with Focal Laser Photocoagulation. Retinal Cases & Brief Reports. 2014;8(2):135-7.

234. Bartolini CE, Goldman DR, Duker JS. Late Reopening of an Initially Successfully Closed Macular Hole After 12 Years. Retinal Cases & Brief Reports. 2014;8(1):30-2.

235. Liu JJ, Witkin JJ, Adhi M, Grulkowski I, Kraus MF, Dhalla AH, Lu CD, Hornegger J, Duker JS, Fujimoto JG. Enhanced Vitreous Imaging in Healthy Eyes using Swept-Source Optical Coherence Tomography. PLos ONE. 2014;9(7):e102950.

236. Novais EA, Badaro E, Regatieri CV, Duker JS, de Oliveira Bonomo PP. Regression of Drusen after Combined Treatment using Photodynamic Therapy with Verteporfin and Ranibizumab. OSLI Retina. Feb 2015;46(2):275-8.

237. Taney LS, Baumal CR, Duker JS. Sustained-Release Dexamethasone Intravitreal Implant for Persistent Macular Edema after Vitrectomy for Epiretinal Membrane. OSLI Retina. Feb 2015;46(2):224-8.

238. Klein KA, Lally DR, Taney LS, Laver NV, Duker JS. Retinal Pigment Epithelial Adenocarcinoma Presenting as an Amelanotic Mass. OSLI Retina. March 2015;46(3):369-372.

239. Mehta M, Rasheed RA, Duker JS, Reichel E, Feinberg E, Husain D, Foster CS, Laver NV. Vitreous Evaluation: A Diagnostic Challenge. Ophthalmology. Mar 2015;122(3):531-7.

240. Ho J, Adhi M, Baumal CR, Liu JJ, Fujimoto JG, Duker JS, Waheed NK. Agreement and Reproducibility of Retinal Pigment Epithelial Detachment Volumetric Measurements through Optical Coherence Tomography. Retina. Mar 2015;35(3):467-72.

241. Lee B, Choi W, Liu JJ, Lu CD, Schuman JS, Wollstein G, Duker JS, Waheed NK, Fujimoto JG. Cardiac-Gated En Face Doppler Measurement of Retinal Blood Flow using Swept-Source Optical Coherence Tomography at 100,000 Axial Scans per Second. IOVS. Apr 2015;56(4)2522-30.

242. Alasil T, Ferrara D, Adhi M, Brewer E, Kraus MF, Baumal CR, Hornegger J, Fujimoto JG, Witkin AJ, Reichel E, Duker JS, Waheed NK. En Face Imaging of the Choroid in Polypoidal Choroidal Vasculopathy using Swept-Source Optical Coherence Tomography. AJO. Apr 2015;159(4):634-43.

243. Droms RJ, Liang MC, Duker JS. Retinoschisis and Outer Retinal Hole Formation in a Patient with Papillorenal Syndrome. OSLI Retina. Apr 2015;46(4):477-80.

244. de Carlo TE, Salz DA, Waheed NK, Baumal CR, Duker JS, Witkin AJ. Visualization of the Retinal Vasculature Using Wide-Field Montage Optical Coherence Tomography Angiography. OSLI Retina. June 2015;46(6):611-616.

245. de Carlo TE, Bonini Filho MA, Chin AT, Adhi M, Ferrara D, Baumal CR, Witkin AJ, Reichel E, Duker JS, Waheed NK. Spectral-Domain Optical Coherence Tomography Angiography of Choroidal Neovascularization. Ophthalmology. Jun 2015;122(6):1228-38.

246. Bonini Filho MA; de Carlo TE, Ferrara D, Adhi M, Baumal CR, Witkin AJ, Reichel E, Duker JS, Waheed NK. Association of Choroidal Neovascularization and Central Serous Chorioretinopathy with Optical Coherence Tomography Angiography. JAMA Ophthalmology. Aug 2015;133(8):899-906.

247. Baumal CR, de Carlo TE, Waheed NK, Salz DA, Witkin AJ, Duker JS. Sequential Optical Coherence Tomographic Angiography for Diagnosis and Treatment of Choroidal Neovascularization in Multifocal Choroiditis. JAMA Ophthalmology. Sept 2015;133(9):1087-90.

248. Flores-Moreno I, Arias-Barquet L; Rubio-Caso MG; Ruiz-Moreno JM, Duker JS, Caminal JM. En Face Swept-Source Optical Coherence Tomography in Neovascular Age-Related Macular Degeneration. British Journal of Ophthalmology. Sept 2015;99(9):1260-7.

249. Ruiz-Medrano J, Flores-Moreno I; Montero JA, Duker JS, Ruiz-Moreno JM. Morphologic Features of the Choroidoscleral Interface in a Healthy Population using Swept-Source Optical Coherence Tomography. AJO. Sept 2015;160(3):596-601.

250. Kuehlewein L, Bansal M, Lenis TL, Iafe NA, Sadda SR, Bonini Filho MA, de Carlo TE, Waheed NK, Duker JS, Sarraf D. Optical Coherence Tomography Angiography of Type 1 Neovascularization in Age-Related Macular Degeneration. AJO. October 2015;160(4):739-748.

251. Novais EA, Adhi M, Moult EM, Louzada RN, Cole ED, Husvogt L, Lee B, Dang S, Regatieri CVS, Witkin AJ, Baumal CR, Hornegger J, Jayaraman V, Fujimoto JG, Duker JS, Waheed NK. Choroidal neovascularization analyzed on ultra-high speed swept source optical coherence tomography angiography compared to spectral domain optical coherence tomography angiography. AJO. 2016;doi:10.1016.

252. de Carlo TE, Chin AT, Joseph T, Baumal CR, Witkin AJ, Duker JS, Waheed NK. Distinguishing Diabetic Macular Edema from Capillary Nonperfusion using Optical Coherence Tomography. OSLI Retina. 2016;47:108-114.

253. de Carlo TE, Bonini Filho MA, Baumal CR, Reichel E, Rogers A, Witkin AJ, Duker JS, Waheed NK. Evaluation of Preretinal Neovascularization in Proliferative Diabetic Retinopathy using Optical Coherence Tomography Angiography. OSLI Retina. 2016;47:115-119.

254. de Carlo TE, Adhi M, Salz DA, Joseph T, Waheed NK, Seddon JM, Duker JS, Reichel E. Analysis of Choroidal and Retinal Vasculature in Inherited Retinal Degenerations using Optical Coherence Tomography Angiography. OSLI Retina. 2016;47:120-127.

255. de Carlo TE, Rosenblatt A, Goldstein M, Baumal CR, Loewentstein A, Duker JS. Vacularization of Irregular Retinal Pigment Epithelial Detachments in Chronic Central Serous Chorioretinopathy Evaluated with OCT Angiography. OSLI Retina. 2016;47:128-133.

256. Cole ED, Novais EA, Louzada RN, Moult EM, Lee BK, Witkin AJ, Waheed NK, Duker JS, Baumal CR. Visualization of Changes in the Choriocapillaris, Choroidal Vessels, and Retinal Morphology After Focal Laser Photocoagulation Using OCT Angiography. IOVS. July 2016;57:356-61.


257. Inoue M, Jung JJ, Balaratnasingam C, Dansingani KK, Dhrami-Gavazi E, Suzuki M, de Carlo TE, Shahlaee A, Klufas MA, El Maftouhi A, Duker JS, Ho AC, Quaranta-El Maftouhi M, Sarraf D, Freund KB, COFT-1 Study Group. A Comparison Between Optical Coherence Tomography Angiography and Fluorescein Angiography for the Imaging of Type 1 Neovascularization. IOVS. July 2016;57:314-23.






REVIEW ARTICLES

1. Duker JS, Blumenkranz MS. Diagnosis and management of the acute retinal necrosis [ARN] syndrome. [86 refs.] Surv Ophthalmol. 1991; 35: 327-343

2. Ginsberg R, Duker JS, Perforations of the globe secondary to retro and peri-bulbar anesthesia injections. [review] [65 refs.] Semin Ophthalmol 1993; 8:87-95.

3. Ginsberg R, Duker JS, Perforation of the globe as a complication of local ocular anesthesia. Curr Opinion in Ophthalmol 1993; 4:50-55.

4. Coker JG, Duker JS. Macular diseases and optical coherence tomography. [review] [28 refs] Curr Opin Ophthalmol 1996, 7:33-38.


CHAPTERS

1. Duker JS Brown GC. Vascular anomalies of the fundus. In: Tasman WS, Jaeger EA, eds., Duane’s Clinical Ophthalmology, Philadelphia, Lippincott, vol 3, ch 22, 1990.

2. Duker JS, Fischer DH. Acute retinal necrosis (ARN) syndrome. In: Tasman WS, Jaeger EA, eds. Duane’s Clinical Ophthalmology, Philadelphia, Lippincott, vol 3, ch 28, 1990.

3. Vander JF, Duker JS, Jaeger EA. Miscellaneous diseases of the fundus. In: Tasman WS, Jaeger EA, eds. Duane’s Clinical Ophthalmology, Philadelphia, Lippincott, vol 3, ch 36, 1990.

4. Duker JS, Weiter JJ. Ocular circulation. In: Tasman WS, Jaeger EA, eds. Duane’s
Foundations of Clinical Ophthalmology, Philadelphia, Lippincott, vol 2, ch 5, 1991.

5. Blumenkranz MS, Duker JS, D’Amico DJ. Acute retinal necrosis. In: Albert DM, Jakobiec F, ed., Principles and Practice of Ophthalmology. Saunders, Philadelphia., vol 2, ch 78, pp 945-962, 1991.

6. Duker JS. Sarcoidosis of the Posterior Segment. In: Tasman WS, ed., Clinical Decisions in Retinal Diseases. Mosby. St. Louis, 1991, p. 348-353.

7. Duker JS. Acute Retinal Necrosis. In: Tasman WS, ed., Clinical Decisions in Medical Retinal Diseases. Mosby. St. Louis, 1994, p.332-338.

8. Duker JS. Cytomegalovirus retinitis. Duane’s Clinical Ophthalmology, Philadelphia, Lippincott, vol. 3, ch. 28A, 1994.

9. Duker JS. Management of post-operative complications: Retinal detachment. In: Steinert R. Cataract Surgery: Technique, Complications and Management. W B Saunders, Philadelphia. 1995. ch. 37, p. 434-438.

10. Reichel E, Duker JS, Puliafito CA. Retinal disorders in the Aged Eye. In, Reichel E, ed. Care of the Elderly: Clinical Aspects of Aging. Williams and Wilkins, Philadelphia 1995. ch. 41, p. 436-440.

11. Duker JS. Glaucoma secondary to intraocular tumors. In, Epstein D, ed. Chandler and Grant’s Glaucoma, Williams and Wilkins, Baltimore, 1997, 4th ed. ch. 41, p. 366-371.

12. Duker, JS. Retinal Detachment, in Steinert R. Cataract Surgery. Lippincott, 1999.

13. Duker JS, Barza M. Infectious uveitis and retinitis. Infectious Disease. Mosby, London, 2000.

14. Laver NV, Sitko K, Duker JS, Farhat NA. Ocular Tumors. In: Linda M. McManus, Richard N. Mitchell, editors. Pathobiology of Human Disease. San Diego: Elsevier; 2014. P. 2179-2200.


BOOKS

1. Yanoff M, Duker JS, eds. Ophthalmology. Mosby, London, 1999.

2. Yanoff M, Duker JS, eds. Ophthalmology, Second Edition. Mosby, London, 2004.

3. Yanoff M, Duker JS, eds. Ophthalmology, Third Edition. Mosby, London, 2009.

4. Yanoff M, Duker JS, eds. Ophthalmology, Fourth Edition. Mosby, London, 2014.

5. Duker JS, Waheed NK, Goldman DR. Handbook of Retinal OCT. Elsevier, Saunders, 2014.

6. Duker JS, Witkin AJ, eds. Age-Related Macular Degeneration – Current Management.
Slack Incorporated, NJ, 2015.


SELECTED ABSTRACTS

1. Duker JS, Brown GC. Central retinal artery obstruction. Ophthalmology 1987
(Suppl); 94:90.

2. Duker JS, Brown GC, McNamara JA. Proliferative sarcoid retinopathy.
Ophthalmology 1988 (Suppl); 95:179.

3. Federman JL, Duker JS, Schubert HS, Talbot CW. Semiconductor diode laser
endophotocoagulation. Lasers Light Ophthalmol 1989; 2(4):A21.

4. Flanagan JC, Duker JS, Talbot CW, Federman JL. Experience with sapphire laser scalpels in oculoplastic procedures. Lasers Light Ophthalmol 1989; 2(4):A18.

5. Duker JS, Brown GC, Colt C, Reber R. Asymmetric proliferative diabetic retinopathy and carotid artery disease. Ophthalmology 1989 (Suppl); 96:87.

6. Sivalingam A, Duker JS, Eagle RC, et al. The presence of internal limiting membrane in histopathologic specimens obtained from epiretinal membrane surgery. Ophthalmology 1989 (Suppl); 96:134.

7. Brown MM, Duker JS, Brown GC, Tasman WS, Augsburger JA. Exudative retinal
Detachment in association with retinopathy of prematurity. Ophthalmology 1989
(Suppl); 96:136

8. Sivalingam A, Duker JS, Brown GC, Magargal LE, Kenney BS, Donoso L. Aqueous basic fibroblast growth factor level in central retinal artery obstruction. Invest Ophthalmol Vis Sci 1990 (Suppl); 31:194.

9. Duker JS, Sivalingam A, Brown GC, Reber R. Ocular neovascularization secondary to acute central retinal artery obstruction. A prospective study. Invest Ophthalmol Vis Sci 1990 (Suppl); 31:569.

10. Duker JS, Belmont JB, Benson WE, Brooks HL, Brown GC, Federman JL, Fischer DH, Tasman WS. Inadvertent globe perforation during retrobulbar and peribulbar anesthesia. Ophthalmology 1990 (Suppl); 97:106.

11. Duker JS, Nielsen JC, Vander JF, Benson WE. The efficacy of retrobulbar bupivicaine irrigation for post-operative pain following scleral buckling surgery. Ophthalmology 1990 (Suppl); 97:154.

12. Duker JS, Fischer DF, Davis JL. Non-Hodgkins lymphoma of the posterior segment
complicating human immunodeficiency virus infection. Ophthalmology 1991 (Suppl); 98:112.

13. Lozano RD, Duker JS, Jalkh A. The significance of lipid exudate associated with subretinal neovascularization in age related macular degeneration. Ophthalmology 1991 (Suppl); 98:124.

14. Brown GC, Lehman R, Duker JS. Combined central retinal artery/central retinal vein obstruction. Ophthalmology 1991 (Suppl); 98:145.

15. Hirose T, Katsumi O, Duker JS, Mehta MC. Fate of stage 4 retinopathy of prematurity (ROP): Analysis of clinical factors. Inv Ophthalmol (Suppl) 1992; 33:1282.

16. Duker JS, Puliafito CA, Kroll AM. Indocyanine green (ICG) angiography in the
differentiation of choroidal melanoma from choroidal metastases. Ophthalmol 1992
(Suppl); 99:136.

17. Duker JS, Anand R, Smith TJ. Initial experience with an eight-month intravitreal sustained release ganciclovir implant for CMV retinitis. Ophthalmol 1992 (Suppl); 99:153.

18. Stroh EM, Duker JS, Sabates NR, Lyon AT. The correlation between cystoid macular edema and intraocular pressure. Ophthalmol 1992 (Suppl); 99:93.

19. Hirose T, Katsumi O, Mehta M, Duker JS, Schepens CL. Management of stage 4 retinopathy of prematurity. Ophthalmology 1992 (Suppl); 99:147.

20. Hedges TR, Reichel E, Duker JS, Puliafito CA, Heggerick PA. Color Doppler imaging identifies different mechanisms of central retinal artery occlusion. Inv Ophthalmol (Suppl) 1993; 34:842.

21. Matsumoto M, Reichel E, Puliafito CA, Duker JS, et al. Detection of choroidal
neovascularization in age related macular degeneration with digital indocyanine green angiography. Inv Ophthalmol (Suppl) 1993; 34:1164.

22. Lin SC, Lin CP, Feld JR, Duker JS, Puliafito CA. Photodynamic closure of choroidal vessels using benzoporphyrin derivative. Inv Ophthalmol (Suppl) 1993; 34:1303.

23. Duker JS, Wendel R, Puliafito CA. Late reopening of macular holes following initially successful vitreous surgery. Ophthalmology 1993 (Suppl); 100:72).

24. Lin CP, Lin SC, Feld DR, Duker JS, Puliafito CA. Measurement of BPD photosensitizer kinetics in retinal and choroidal vessels by fluorescence imaging. Inv Ophthalmol (Suppl) 1994; 34:1168.


INVITED LECTURES

1. Guest Speaker, Neovascularization associated with central retinal artery obstruction. American Academy of Ophthalmology, Dallas, TX, 1987.

2. Guest Speaker, Optic neuritis with secondary retinal venous stasis. Wills Eye Hospital Annual Conference, Philadelphia, PA, 1988.

3. Guest Speaker, Proliferative Sarcoid Retinopathy (poster). American Academy of Ophthalmology, Las Vegas, NV, 1988.

4. Guest Speaker, The efficacy of panretinal photocoagulation for neovascularization of the iris after central retinal artery obstruction. Wills Eye Hospital Annual Conference, Philadelphia, PA, 1989.

5. Guest Speaker, The presence of internal limiting membrane in histopathologic specimens obtained from epiretinal membrane surgery: Visual significance. Wills Eye Hospital Annual Conference, Philadelphia, PA, 1989.

6. Guest Speaker, Semiconductor diode laser endophotocoagulation. Second International Congress on Laser Technology in Ophthalmology. Lugano, Switzerland, 1989.

7. Guest Speaker, Experience with sapphire laser scalpels in oculoplastic procedures. Second International Congress on Laser Technology in Ophthalmology. Lugano, Switzerland, 1989.

8. Guest Speaker, Ocular neovascularization secondary to acute central retinal artery obstruction: A prospective study. Second International Symposium on Ocular Circulation and Neovascularization. Baltimore, MD, 1989.

9. Guest Speaker, Asymmetric proliferative diabetic retinopathy and carotid artery disease. American Academy of Ophthalmology, New Orleans, LA, 1989.

10. Guest Speaker, Semiconductor Diode Lasers. In: Update on Retinal Vascular Disorders. Wills Eye Hospital, Philadelphia, PA, 1989.

11. Guest Speaker, Inadvertent globe perforation during retrobulbar and peribulbar anesthesia for ocular surgery. Wills Eye Hospital Annual Conference, Philadelphia, PA, 1990.

12. Guest Speaker, Ocular neovascularization secondary to acute central retinal artery obstruction: A prospective study. Association for Research in Vision and Ophthalmology, Sarasota, FL, 1990.

13. Guest Speaker, Long term visual prognosis following successful panretinal photocoagulation for proliferative diabetic retinopathy. Schepens Alumni Society, Boston, MA, 1990.

14. Guest Speaker, Inadvertent globe perforation during retrobulbar and peribulbar anesthesia. American Academy of Ophthalmology, Atlanta, GA, 1990.

15. Guest Speaker, The efficacy of retrobulbar bupivicaine irrigation for post-operative pain following scleral buckling surgery (poster). American Academy of Ophthalmology, Atlanta, GA, 1990.

16. Guest Speaker, Long term visual prognosis following successful panretinal photocoagulation for proliferative diabetic retinopathy. Massachusetts Eye and Ear Alumni Meeting, Boston, MA, 1991.

17. Guest Speaker, Non-Hodgkins lymphoma of the posterior segment complicating human immunodeficiency virus infection (poster). American Academy of Ophthalmology, Anaheim, CA, 1991.

18. Guest Speaker, The significance of lipid exudate associated with subretinal neovascularization in age related macular degeneration (poster). American Academy of Ophthalmology, Anaheim, CA, 1991.

19. Guest Speaker, Indocyanine green (ICG) angiography in the differentiation of choroidal melanoma from choroidal metastases (poster). American Academy of Ophthalmology, Dallas, TX, 1992.

20. Guest Speaker, Initial experience with an eight-month intravitreal sustained release ganciclovir implant for CMV retinitis (poster). American Academy of Ophthalmology, Dallas, TX, 1992.

21. Guest Speaker, Posterior Segment Abnormalities in Human Immunodeficiency Virus (HIV) Infection, Rhode Island Hospital, Brown University, Providence, RI, 1991.

22. Guest Speaker, Update in Posterior Segment Disease – 1991. American Academy of Ophthalmology, Anaheim, CA, 1991.

23. Guest Speaker, Arterial Obstructive Disease of the Retina. Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, 1991.

24. Guest Speaker, Flashes, Floaters and Retinal Detachments. Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, 1991.

25. Guest Speaker, Retinal Vascular Emergencies. Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, 1991.

26. Guest Speaker, Digital and Indocyanine Green Angiography, New England Eye Center, Tufts University School of Medicine, Boston, MA, 1992.

27. Guest Speaker, Treatment of Common Retinal Disorders. Orlando, FL, 1992.

28. Guest Speaker, Color Doppler Imaging in Ophthalmology. New England Eye Center, Boston, MA, 1992.

29. Guest Speaker, HIV and the Eye. Internal Medicine Grand Rounds, Lawrence Memorial Hospital, Boston, MA, 1992.

30. Guest Speaker, Ganciclovir Implant for CMV Retinitis. Vitreoretinal Frontier, Dallas, TX, 1992.

31. Guest Speaker, Retinal vascular diseases and ICG angiography. Ahemdebad Academy of Optometry, Ahemdebad, India, 1993.

32. Guest Speaker, HIV and the Eye. Ophthalmology Grand Rounds, Lahey Clinic, Burlington, MA, 1993.

33. Guest Speaker, Diagnostic Testing in Age Related Macular Degeneration. American Academy of Optometry, Boston, MA, 1993.

34. Guest Speaker, Squaw Valley Retinal Symposium, Squaw Valley, CA, 1994.

35. Guest Speaker, Retinal Symposium, Mexico City, Mexico, 1994.

36. Guest Speaker, Indianapolis Ophthalmologic Society, Indianapolis, IN, 1994.

37. Guest Speaker, Retina Symposium. New England Ophthalmology Society, Boston, MA, 1995.

38. Guest Speaker, Squaw Valley Retinal Symposium, Squaw Valley, CA, 1995.

39. Guest Speaker, Frontiers in Ophthalmology, Scottsdale, AZ, 1995.

40. Guest Speaker, Pre-Academy Retinal Symposium, Atlanta, GA, 1995.

41. Guest Speaker, Nassau County Surgical Society, Uniondale, NY, 1995.

42. Guest Speaker, New England Ophthalmologic Society, Boston, MA, 1996.

43. Guest Speaker, New England Ophthalmologic Society, Boston, MA, 1997.

44. Guest Speaker, Squaw Valley Retinal Symposium, Squaw Valley, CA, 1997.

45. Guest Speaker, ASCRS Meeting, Boston, MA, 1997.

46. Guest Speaker, Acute Retinal Necrosis (ARN) Syndrome, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, 1998.

47. Guest Speaker, Squaw Valley Retinal Symposium, Squaw Valley, CA, 1998.

48. Guest Speaker, “The Management of Intraoperative Choroidal Hemorrhage”; New England Ophthalmological Society, Boston, MA, 1998.

49. Guest Speaker, Pre-Academy Retinal Symposium, Orlando, FL, 1999.

50. Guest Speaker, New England Ophthalmologic Society, Boston, MA, 1999.

51. Guest Speaker, New England Ophthalmologic Society, Boston, MA, 2000.

52. Guest Speaker, Pre-Academy Retinal Symposium, Dallas, TX, 2000.

53. Guest Speaker, New England Ophthalmologic Society, Boston, MA, 2000.

54. Guest Speaker, Pre-Academy Retinal Symposium, New Orleans, LA, 2001.

55. Guest Speaker, New England Ophthalmologic Society, Boston, MA, 2001.

56. Guest Speaker, Squaw Valley Retinal Symposium, Squaw Valley, CA, 2002.

57. Guest Speaker, Hawaii ’02 & Retina ’02, The Big Island, HI, 2002.

58. Guest Speaker, New England Ophthalmological Society, Boston, MA, 2002.

59. Guest Speaker, Vermont Ophthalmological Society, Stowe, VT, 2002.

60. Guest Speaker, American Academy of Ophthalmology, Orlando, FL, 2002.

61. Guest Speaker, 25-Gauge Sutureless Vitreous Surgery; Prototype Instruments; Intravitreal Kenalog for Diabetic Macular Edema; OCT Imaging of the Retina; Management of Retinal Arterial and Venous Occlusion; OCT: The Next Generation and Beyond, Hawaii ’03 and Retina ’03 Meeting, Maui, HI, January, 2003.

62. Guest Speaker, Intravitreal Kenalog for Diabetic Macular Edema, Grand Rounds Professorship, Long Island Jewish Hospital, Long Island, NY, February, 2003.

63. Guest Speaker, Treatments for Macular Degeneration, Sheraton Colonial & Golf Club, Wakefield, MA, April, 2003.

64. Guest Speaker, Intravitreal Steroids for Macular Edema; Rhode Island Hospital, Providence, RI, April, 2003.

65. Guest Speaker, Intravitreal Kenalog for Macular Edema; Columbus EENT Society, Columbus, OH, April, 2003.

66. Guest Speaker, The Use of Intravitreal Corticosteroids in Diabetic Macular Edema; 25-Gauge Sutureless Vitrectomy, High Resolution OCT; The Results and Complications of Macular Hole Surgery, XXVIII Congress of the Brazilian Society of Retina and Vitreous, Goiania, Brazil, April, 2003.

67. Guest Speaker, Photodynamic Therapy for Choroidal Neovascularization in Young Patients; Cole Eye Institute at the Cleveland Clinic Foundation, Cleveland, OH, May, 2003.

68. Guest Speaker, The Clinical Utility of Optical Coherence Tomography (OCT) in Macular Disease, Grand Rounds Professorship, Bascom Palmer Eye Institute, Miami, FL, September, 2003.

69. Guest Speaker, Macular Degeneration Treatment in 2003; Investigational Treatments for ARMD; Optical Coherence Tomography for Macular Disease; Retinal Vein Occlusions; Investigational Treatments of Diabetic Retinopathy, 2nd Annual Downeast Ophthalmology Symposium, Bar Harbor, ME, September, 2003.

70. Guest Speaker, Controversies in Macular Hole Management, New England Ophthalmological Society, Boston, MA, October, 2003.

71. Guest Speaker, OCT for Macular Hole: Diagnosis, Staging, Surgical Management, Clinical Applications of Optical Coherence Tomography - New England Eye Center/TUSM Course, Boston, MA, October, 2003.

72. Guest Speaker, OCT for Macular Hole: Diagnosis, Staging, Surgical Management; Vitreomacular Traction Syndrome, Epiretinal Membrane and Others, Clinical Applications of Optical Coherence Tomography, Pittsburgh, PA, November, 2003.

73. Guest Speaker, Optical Coherence Tomography: High Resolution Technology; Chronic Cystoid Macular Edema; Stratus OCT Retinal Applications for the Comprehensive Ophthalmologists, American Academy of Ophthalmology Meeting, Anaheim, CA, November, 2003.

74. Guest Speaker, Stump Jerry, Atlantic Coast Retina Club Meeting, Baltimore, MD, January, 2004.

75. Guest Speaker, OCT Imaging of the Retina; Controversies in Macular Hole Surgery; Update in Intravitreal Kenalog; Long Term Efficacy and Complications of the Ganciclovir Implant; High Resolution OCT – What’s New?, The Royal Hawaiian Eye Meeting, Kauai, HI, January, 2004.

76. Guest Speaker, New Findings with Ultra High Resolution OCT, Vail Vitrectomy Meeting, Vail, CO, March, 2004.

77. Guest Speaker, The Utility of OCT for Macular Disease; What’s New in Macular Degeneration Therapy?; Retinal Artery Obstructions-Diagnosis and Management. The 21st Annual Wake Forest University Eye Center Conference, Winston-Salem, NC, April 2004.

78. Guest Speaker, New Treatments for Retinal Vascular Diseases. Optometric Retina Society Educational Conference, Boston, MA, April 2004.

79. Guest Speaker, Diabetic Macular Edema: Should I Sell My Laser? New England Ophthalmological Society, Inc., Boston, MA, April 2004.

80. Guest Speaker, Optical Coherence Tomography (OCT) in Macular Disease: Utility for the General Ophthalmologist; Intravitreal Kenalog-A New Treatment for Macular Edema. Connecticut Society of Eye Physicians Annual Meeting, Plantsville, CT, June 2004.

81. Guest Speaker, Ultrahigh Resolution OCT. Nantucket Retina Meeting, Nantucket, MA, July 2004.

82. Guest Speaker, Intravitreal Kenalog for Macular Edema; Clinical Utility of OCT. 36th Annual Conference of Michigan Ophthalmological Society, Acme, MI, August 2004.

83. Guest Speaker, The Utility of Optical Coherence Tomography in Macular Disease; Intravitreal Kenalog for Diabetic Macular Disease; Current Management of Retinal Venous Disease. 8th Annual Symposium – Rocky Mountain Eye Institute, Aurora, CO, September 2004.

84. Guest Speaker, Ultra-High Resolution OCT; The Reappraisal of Macular Hole Staging. The Roy Wilkerton Lecture, Washington, DC, October 2004.

85. Guest Speaker, Evaluating Macular Holes using the OCT. Advanced Imaging Training, Boston, MA, October 2004.

86. Guest Speaker, Age Related Macular Degeneration; OCT: Fourth Generation and Beyond. American Academy of Ophthalmology Meeting, New Orleans, LA, October 2004.

87. Guest Speaker, OCT/Retinal Imaging Interpretations. New England Ophthalmological Society Meeting, Boston, MA, November 2004.

88. Guest Speaker, Ultrahigh Resolution OCT; Macular Hole Staging: Time for an Update; OCT Imaging of the Retina. Hawaii 2005-The Royal Hawaiian Eye Meeting, The Big Island of Hawaii, January 2005.

89. Guest Speaker, The Clinical Utility of OCT in Macular Disease; Ultrahigh Resolution OCT. 2005 Medical College of Wisconsin Mid-Winter Retina Symposium, Brookfield, WI, February 2005.

90. Guest Speaker, OCT, FA and ICG in AMD Management. New England Ophthalmological Society, Boston, MA, March 2005.

91. Guest Speaker, Ultrafast, Ultrahigh Resolution OCT; Management of ARMD: 2005; The Utility of OCT for the Diagnosis and Management of Macular Disease. University of Cincinnati/CSO Meeting, Cincinnati, OH, March 2005.

92. Guest Speaker, Avoiding the Most Common Causes of Litigation Against Ophthalmologists; Risk Management Issues in Vitreoretinal Disease. Ophthalmic Risk Management and Patient Safety Summit 2005, Bascom Palmer Eye Institute, Miami, FL, March 2005.

93. Guest Speaker, Next Generation OCT. Retinal Physician Symposium, Nassau, Bahamas, May 2005.

94. Guest Speaker, Ultrahigh Resolution OCT. Nantucket Retina Meeting, Nantucket, MA, July 2005.

95. Guest Speaker, Treatment of Age-Related Macular Degeneration 2005. Fourteenth Annual Ocular Surgery News Symposium on Cataract, Glaucoma & Refractive Surgery, New York, NY, September 2005.

96. Guest Speaker, Stump Jerry. Wills Eye Hospital Retina Club Meeting, Philadelphia, PA, October 2005.

97. Guest Speaker, OCT High Resolution; Ultrahigh Resolution with OCT. American Academy of Ophthalmology, Chicago, IL, October 2005.

98. Guest Speaker, Optical Coherence Tomography in the Assessment of the Vitreoretinal Interface; High Resolution and Spectral OCT: The Tufts and New England Eye Center Experience. Retinal and Glaucoma Imaging 2006: Optical Coherence Tomography (OCT) Applications and Future Technology, Bascom Palmer Eye Institute, Palm Beach, FL, December 2005.

99. Guest Speaker, What is the Role for Intravitreal Avastin in the Management of Choroidal Neovascularization?; Cataract Surgery Complications; Surgical Challenges in Vitreoretinal Disease; Ultrahigh Resolution OCT in Retinal Disease; Macular Hole Surgery; Endophthalmitis after Cataract Surgery; New Retinal Technologies. Hawaiian Eye 2006, Maui, HI, January 2006.

100. Guest Speaker, Ocular Imaging; Instrumentation in Vitreoretinal Surgery. World Ophthalmology Congress, Sao Paulo, Brazil, February 2006.

101. Guest Speaker, Treatment Algorithms in the Management of Diabetic Macular Edema; Work-Up for the Retinal Vascular Occlusions; Treatment of Retinal Vein Occlusion. 58th Annual Wills Eye Hospital Alumni Conference, Philadelphia, PA, March 2006.

102. Guest Speaker, Targeting Choroidal Neovascularization for Age-Related Macular Degeneration. Eye Exchange Network, University of Louisville – Kentucky Lions Eye Center, April 2006.

103. Guest Speaker, Introducing a New Option for the Treatment of Neovascular Age-Related Macular Degeneration (AMD): LUCENTIS for Intravitreal Use. GENentech Integrated Education Speakers’ Bureau, Garden City, NY, October 2006.

104. Guest Speaker, Stump Jerry. Wills Eye Retina Club Meeting, Philadelphia, PA, October 2006.

105. Guest Speaker, Introducing a New Option for the Treatment of Neovascular Age-Related Macular Degeneration (AMD): LUCENTIS for Intravitreal Use. Genentech Integrated Education Speakers’ Bureau, Sacramento, CA, October, 2006.

106. Guest Speaker, 3-Dimensional High-Resolution OCT in Macular Diseases. Optovue Meeting at AAO, Las Vegas, NV, November 2006.

107. Guest Speaker, The Clinical Utility of OCT in Macular Disease. OCT Dinner/Lecture-Hotel Albuquerque, Albuquerque, NM, November, 2006.

108. Guest Speaker, Optical Coherence Tomography in the Management of the Vitreoretinal Interface; High Resolution OCT: The Tufts Experience. Retinal & Glaucoma Imaging 2007: Optical Coherence Tomography (OCT) Applications and Future Technology, West Palm Beach, FL, December, 2006.

109. Guest Speaker, A Treatment Algorithm for Diabetic Retinopathy. Hawaiian Eye 2007, Kauai, HI, January, 2007.

110. Guest Speaker, Pattern Recognition in OCT-Based Diagnosis; Clinical Insights from Ultrahigh Resolution OCT; PDT in Era of anti-VEGF’s….role? 26th Annual Squaw Valley Retinal Symposium, Olympic Valley, CA, February, 2007.

111. Guest Speaker, Is there a Role for PDT in the Era of Anti-VEGF Therapy? Angiogenesis 2007, Key Biscayne, FL, February, 2007.

112. Guest Speaker, The Initial Anatomic and Visual Response to Lucentis. Vail Vitrectomy 2007, Vail, CO, March, 2007.

113. Guest Speaker, Clinical Aspects and Physiopathology of AMD; Lucentis Therapy for Age-Related Macular Degeneration; New Innovations in OCT. 32nd Brazilian Retina and Vitreous Society Meeting, Uberlandia, Minas Gerais, April, 2007.

114. Guest Speaker, Innovations in OCT – What’s Here and What’s Coming. Annual Business Meeting-Massachusetts Society of Eye Physicians and Surgeons, Waltham, MA, May, 2007.

115. Guest Speaker, OCT’s Role in Surgical Management of Macular Diseases; Understanding of Ultrahigh Resolution OCT; An Algorithm for the Treatment of Diabetic Macular Edema; Pattern Recognition. III Curso Interactivo Retina y Vitreo 2007 Meeting, Cartagena, Colombia, September, 2007.

116. Guest Speaker, High Resolution OCT; Focal and Multifocal Electroretinography; Venous Occlusion Treatment Innovations. The Ocular Immunology & Uveitis Foundation’s Second Physician Education Conference, Cambridge, MA, October 2007.

117. Guest Speaker, 3-D High Resolution OCT; RTVue in the Management of Macular Disease. AAO, New Orleans, LA, November 2007.

118. Guest Speaker, OCT in the Management of Vitreo-Macular Interface; High Resolution OCT: The Tufts Experience. Retinal and Glaucoma Imaging 2008, Palm Beach, FL, December 2007.

119. Guest Speaker, Stump Jerry. Atlantic Coast Retina Club Meeting, Wills Eye Institute, Philadelphia, PA, January 2008.

120. Guest Speaker, Anatomic Response to anti-VEGF Agents in ARMD; Pars Plana Anterior Vitrectomy by Cataract Surgeons-Con?; Ultrahigh Resolution OCT-What has it Taught Us?; New Imaging Techniques for Retinal Disease. Hawaiian Eye Meeting, The Big Island, HI, January 2008.

121. Guest Speaker, OCT in the Diagnosis and Management of Macular Disease; Diabetic Retinopathy Management in 2008; What is New is OCT-2008 and Beyond?; Interesting Retina Cases. Montana Academy Meeting at Big Sky Resort, Big Sky, MO, February, 2008.

122. Guest Speaker, Advantages and Disadvantages of Spectral OCT; Macular Hole Closure Rate using 23 Gauge Surgery and No Adjuvants; Photodynamic Therapy in 2008: Is there a Role? Spanish Vitreoretinal Society Meeting, Zaragoza, Spain, March, 2008.

123. Guest Speaker, Spectral Domain – What is New?; OCT in the Management of VitreoSurface Disorders; Treatment Tendencies in Vascular Occlusion of the Retina. 33rd Retina and Vitreo Brazilian Society Meeting, Salvador, Brazil, April, 2008.

124. Guest Speaker, AMD: Image and Evaluations. ARVO Meeting, Fort Lauderdale, Florida, April, 2008.

125. Guest Speaker, What’s the Latests in OCT?: Illinois Eye and Ear Infirmary-Alumni Weekend 2008, Chicago, Illinois, June, 2008.

126. Guest Speaker, Anatomic Response to Treatment in Wet ARMD: Implications for Repeat Treatment. Oph2000 Principal Investigator’s Meeting, New York, New York, July, 2008.

127. Guest Speaker, The Anatomic Response to Anti-VEGF Therapy, and the Effect of Variable Dosing Regimens in the Treatment of Wet AMD; Current Management of CRVO; Spectral Domain OCT-What is it good for?; OCT in the Management of Vitreomacular Surface Diseases. AVTT Symposium, Chicago, Illinois, August, 2008.

128. Guest Speaker, Bryan St. L. Liddy Lecture - Intraocular Steroids-Where We Are and Where We Are Going; OCT-Can We No Longer Live Without it in Retina?; DR Treatment-Interactive Case Discussion. 40th Sally Letson Foundation-Medical and Surgical Retina Update, Ottawa, Canada, September, 2008.

129. Guest Speaker, Spectral Doman Optical Coherence Tomography. NEOS Meeting, Boston, Massachusetts, October, 2008.

130. Guest Speaker, Comparison of OCT Equipment; Cirrus HD-OCT: Advanced Imaging Capabilities for Differential Diagnosis in Macular Diseases; Anterior Vitrectomy Principles. American Academy of Ophthalmology, Atlanta, Georgia, November, 2008.

131. Guest Speaker, High Speed Cutting: Practical Considerations for the Vitreous Surgeon; Ultrahigh Resolution OCT: The Tufts Experience; Optical Coherence Tomography in the Management of Vitreo Macular Surface Disorders; Cirrus™ HD-OCT for Power Users; Initial Anatomic Response to Anti-VEGF Therapy in Wet AMD; Managing the Posteriorly Dislocated IOL-Should it Stay or Should it Go?; 23-Gauge Vitrectomy Without Adjuvants for Macular Hole Surgery; Gamma Knife Therapy for Choroidal Melanoma. Hawaiian Eye 2009 Meeting, Maui, Hawaii, January, 2009.

132. Guest Speaker, CT. NEW FRONTIERS IN RETINA DIAGNOSIS AND THERAPY, NEW YORK CITY, NY, APRIL, 2009.

133. Guest Speaker, Update on Spectral Domain OCT: What is it? What is it good for? University of New Mexico, Albuquerque, New Mexico, April, 2009.
134. Guest Speaker, OCT as a Tool in Determining Retreatment with anti-VEGF Agents. ARMD and Retinal Vascular Diseases 2009: An Intensive Review. Boston, MA, September, 2009.

135. Guest Speaker, OCT Instrumentation Overview; The Retinal Interface. AAO – Retina Overview. San Francisco, CA, October, 2009.

136. Guest Speaker, Stump Jerry. Wills Retina Club Meeting. Philadelphia, PA, November, 2009.

137. Guest Speaker, Spectral Domain OCT in the Diagnosis and Management of Vitreoretinal Interface Disorders. Retinal and Glaucoma Imaging 2010. Palm Beach, FL, December, 2009.

138. Guest Speaker, Newest Developments in Vitrectomy Technology; OCT in the Management of Vitreomacular Surface Disorders; OCT-What’s Next?; Gamma Knife Therapy for Choroidal Melanoma; Macular Hole Surgery Update. Hawaiian Eye 2010 Meeting. Kauai, Hawaii, January, 2010.

139. Guest Speaker, OCT: Past, Present and Future; OCT Case Presentations. Imaging Update 2010. Milwaukee, Wisconsin, February, 2010.

140. Guest Speaker, OCT for Diseases of the Vitreoretinal Interface; Retinal Whitening. Georgetown University Hospital, Washington, DC, February, 2010.

141. Guest Speaker, Retina: Then and Now. NEOS Meeting, Boston, MA, February, 2010.

142. Guest Speaker, Spectral Domain OCT; Evaluation & Management of Retinal Vascular Disease; Treatment Algorithm for DME; What’s New in Posterior Segment Tumors; Controversies and Complications in Macular Hole Surgery. 2010 Annual Scientific Meeting, Sydney, Australia, March, 2010.

143. Guest Speaker, Application on the Retina (OCT Fourier Domain) ; OCT for Diseases of the Vitreomacular Interface; Using SD OCT to Limit Facedown Positioning after Macular Hole Surgery. Brazilian Retina Congress, Sao Paolo, Brazil, April, 2010.

144. Guest Speaker, OCT: Past, Present and Future. MSEPS Annual Meeting, Weston, MA, May, 2010.

145. Guest Speaker, Cataract Surgery and ARMD: Should We Worry? NEOS Meeting, Boston, MA, June, 2010.

146. Guest Speaker, OCT-Past, Present and Future. OCT for Evaluation of the Vitreomacular Interface. Update in the Management of Retinal Vein Obstruction in 2010. Downeast Ophthalmology Symposium, Bar Harbor, ME, September 2010.

147. Guest Speaker, OCT-Past, Present and Future. White Spots in the Retina. Macular Hole and Other Diseases of the Vitreoretinal Interface. Visiting Professor, Dalhousie University, Halifax, Nova Scotia, October 2010.

148. Guest Speaker, OCT: Where are we going? Tips for Identifying and Correcting Common OCT Artifacts. AAO, Chicago, IL October 2010.

149. Guest Speaker, Spectral Domain OCT in the Diagnosis and Management of Vitreoretinal Interface. Imaging 2011, West Palm Beach, FL, December 2010.

150. Guest Speaker, OCT: What’s Coming. The Choroid in Macular Disease. Initial Anatomic Response to Anti-VEGF Therapy in Wet AMD. The Evolution of Small Gauge Surgery: When Should You Use a Small Gauge Format? Using OCT to Limit Face Down Positioning After Macular Hole Surgery. Hawaiian Eye 2011, Maui, HI, January 2011.

151. Guest Speaker, Stump Jerry. OCT for Diseases of the Vitreomacular Interface. The Macula 2011 and AtlanticCoast Retina Club Meeting, Philadelphia, PA, January 2011.

152. Guest Speaker, Macular OCT Interpretation. OCT in Management of Diseases of the Vitreomacular Interface. OCT-Past, Present and Future. Knobloch Visiting Professor, Minneapolis, MN, February 2011.

153. Guest Speaker, Imaging in the Management of Diabetes. Macular Hole Surgery-Tips and Tricks. 7th Annual Retinal Physician Symposium, Las Vegas, NV, February 2011.

154. Guest Speaker, Imaging in the Management of Diabetic Retinopathy. Keynote Address: Macular Hole Surgery-Tips and Tricks. North Coast Retina Symposium, Cole Eye Institute, May, 2011.

155. Guest Speaker, Update in the Management of CRVO and BRVO 2011. ARMD and Retinal Vascular Diseases: New Studies, New Decisions, Boston, MA, May 2011.

156. Guest Speaker, White Spots-Interesting Uveitis and Tumor Cases that Produce Whitening of the Retina. Bi-Annual Vanderbilt Ocular Angiography Conference, Nashville, TN, August 2011.

157. Guest Speaker, Diagnostics Strategies OCT and Angiography, Therapy. Ocular Immunology and Uveitis Foundation-2011 Summit on Posterior Segment Therapy, Cambridge, MA, September 2011.

158. Guest Speaker, Stump Jerry. Wills Eye Institute Retina Club Meeting, Philadelphia, PA, September 2011.

159. Guest Speaker, To Infinity and Beyond: OCT, The Next Frontier. OCT: Mastering the Basics. Diagnostic Imaging in DME. AAO, Orlando, FL, October 2011.

160. Guest Speaker, Management of Retinal Vein Obstruction. White Retinal Cases. North Shore Long Island Jewish Health System, Great Neck, NY, November 2011.

161. Guest Speaker, Cataract Surgery and AMD – Should We Worry? Vitreoretinal Disease Update: Posterior Segment Complications of Anterior Segment Surgery, Philadelphia, PA, December 2011.

162. Guest Speaker, OCT Artifacts: Recognition and Avoidance. OCT for the Vitreoretinal Interface. Ultrahigh Resolution OCT of Foveal Disorders. Imaging for Diabetic Retinopathy 2012. Imaging in the Management of Diabetic Retinopathy. Macular Hole Surgery: Tips and Tricks. Hawaii Meeting Retina 2012, Maui, HI, January 2012.

163. Guest Speaker, OCT Technology-What is Coming. 2nd Euretina Winter Meeting, Rome, Italy, January 2012.

164. Guest Speaker, Tips for Recognizing and Correction of Common OCT Artifacts. AMD and Cataract Surgery. OCT in the Management of the Vitreoretinal Interface. Update in Imaging in Diabetic Retinopathy. Choroidal Imaging with SD OCT. The Future of SD OCT. 26th Annual Sarasota Vitreo-Retinal Update Course, Sarasota, FL, February 2012.

165. Guest Speaker, Ophthalmic Imaging. Retinal Disease Summit 2012, Newport Beach, CA, March 2012.

166. Guest Speaker, Imaging in Diabetic Retinopathy. OCT-What is Coming? Macular Hole Surgery Update 2012-Does Positioning Matter? Rare Causes of Peripheral Retinal Elevations. Cataract
Surgery in AMD-Should We Worry? The Choroid in Macular Disease; Imaging in ARMD; Wet AMD Therapy-Why Not Just Treat Monthly? Treatment of Retinal Vein Obstruction. 37th Congress of the Brazilian Society of Retina and Vitreous, Rio de Janeiro, Brazil,
April 2012.

167. Guest Speaker, OCT of the Vitreomacular Interface. OCT in the Management of Diabetic Retinopathy. Clinical Applications of Optical Coherence Tomography, Pittsburgh, PA, July 2012.

168. Guest Speaker, Imaging in Patients with VMA/VMT and Macular Hole/ERM. Optical Coherence Tomography Experts Review, Las Vegas, NV, August 2012.

169. Guest Speaker, OCT Imaging, Beware the Pitfalls. Evaluation and Treatment of CME after Cataract Surgery. Retina Update and Case Conference, Minneapolis, MN, September 2012.

170. Guest Speaker, OCT Interpretation and Artifacts I. Diagnosis and Management of Lamellar Macular Hole. Utility of OCT in the Peripheral Retina. Brazilian Meeting – Modulo I, Indaiatuba, Brazil, October 2012.

171. Guest Speaker, Macular OCT: Mastering the Basics. Imaging in DME. Retinal Imaging-The Vitreoretinal Interface. American Academy of Ophthalmology, Chicago, IL, November 2012.

172. Guest Speaker, High Resolution OCT in the Diagnosis of Challenging Macular Disorders. Ophthalmic Imaging 2013: Optical Coherence Tomography (OCT) Applications and Future Technology, Palm Beach, FL, December 2012.

173. Guest Speaker, The Future of Spectral Domain OCT. Addressing Postsurgical Complications in Retinal Surgery. AMD and Cataract Surgery-Should We Worry? Pharmaceuticals: Injection Revolution. The Future of Spectral Domain OCT. Hawaiian Eye Meeting, The Big Island, HI, January 2013.

174. Guest Speaker, Complement Inhibition Using Gene Therapy for AMD. Angiogenesis, Exudation and Degeneration 2013, Miami, FL, February 2013.

175. Guest Speaker, Future OCT Hardware Advances. International Retinal Imaging Symposium, Los Angeles, CA, February 2013.

176. Guest Speaker, Part I: Pathogenesis, Diagnosis and Classification. Part II: Management with Observation and Surgery. Contemporary Management of Diseases of the Vitreomacular Interface: A Comprehensive Review, New York, NY, March 2013.

177. Guest Speaker, Innovations in ARMD. Retinal Innovation Symposium, Boston, MA, April 2013.

178. Guest Speaker, Update on HD-OCT-What’s Coming? New England Ophthalmological Society Meeting, Boston, MA, April 2013.

179. Guest Speaker, Unusual Surgical Situations: Pediatrics, Intraocular Tumors and Uveitis – JSD Moderator. The Vit-Buckle Society Meeting, Miami, FL, April 2013.

180. Guest Speaker, Pathogenesis, Classification and Management of Diseases of the Vitreomacular Interface. Maine Society of Eye Physicians and Surgeons, Freeport, ME, May 2013.

181. Guest Speaker, The Private-Practice Oriented Academic Practice. University of Kentucky Vision Healthcare Summit, Lexington, KY, May 2013.

182. Guest Speaker, Vision for the Future: Focusing on DME and RVO Treatment in Your Practice – Discussion. CME Incite, Boston, MA, June 2013.

183. Guest Speaker, Part I: Pathogenesis, Diagnosis and Classification. Contemporary Management of Diseases of the Vitreomacular Interface: A Comprehensive Review, Chicago, IL, June 2013.

184. Guest Speaker, Part I: Pathogenesis, Diagnosis and Classification. Contemporary Management of Diseases of the Vitreomacular Interface: A Comprehensive Review, Boston, MA, July 2013.

185. Guest Speaker, A New International Classification System for Diseases of the Vitreomacular Interface. Macula 2014 Conference, Philadelphia, PA, January 2014.

186. Guest Speaker, Hawaiian Eye Meeting, Kauau, Hawaii, January 2014.

187. Guest Speaker, Angiogenesis, Exudation, and Degeneration, Miami, Florida, February 2014.

188. Visiting Guest Speaker, Canadian Retina Society and Canadian Ophthalmological Society, Whistler, British Columbia, February 2014.

189. Guest Speaker, Oregon Ophthalmology Society, Portland, Oregon, March 2014.

190. Guest Speaker, Albany Ophthalmology Update, Troy, New York, May 2014.

191. Guest Speaker, New York Retina Club Meeting (IRIS II), New York, New York, June 2014.

192. Guest Speaker, ASRS Meeting, Cole Eye Institute Imaging Summit, San Diego, California, August 2014.

193. Guest Speaker, New England Ophthalmological Society, Boston, Massachusetts, August 2014.

194. Guest Speaker, Seslen Lecture, The Retina Institute, St. Louis, Missouri, August 2014.

195. Guest Speaker, Retina in 3D: Future Trends of Diagnositics, Drugs and Devices, Philadelphia, PA, September 2014.

196. Guest Speaker, Vitreomacular Traction and Macular Hole: Treatment Selection and Injection Technique to Optimize Workshop, Boston, Massachusetts, September 2014.

197. Guest Speaker, Alcon Canada Road Trip, Toronto, Ontario, September-October 2014.

198. Guest Speaker, American Academy of Ophthalmology, Chicago, Illinois, October 2014.

199. Guest Speaker, Brazilian Retina and Vitreous Society, Florianopolis, Brazil, October 2014.

200. Guest Speaker, Ophthalmic Imaging 2015: Optical Coherence Tomography (OCT) Applications and Future Technology, Palm Beach, Florida, December 2014.

201. Guest Speaker/Co-Director, ACRC/Macula 2015, Boston, Massachusetts, January, 2015.

202. Guest Speaker, Hawaiian Eye Meeting, Maui, Hawaii, January 2015.

203. Guest Speaker, Angiogenesis 2015, Miami, Florida, February 2015.

204. Guest Speaker, USC Frontiers of Optical Coherence Tomography, Pasadena, California, February, 2015.

205. Guest Speaker, International Retinal Imaging Symposium (IRIS III), Los Angeles, California, March 2015.

206. Guest Speaker, New England Ophthalmological Society, Boston, Massachusetts, April 2015.

207. Guest Speaker, Brazilian Retina and Vitreous Society, Florianopolis, Brazil, April 2015.

208. Guest Speaker, Retina Conference, New England Eye Center, Boston, Massachusetts, June 2015.

209. Guest Speaker, American Society of Retina Specialists, Cole Eye Institute Imaging Summit, Vienna, Austria, July 2015.

210. Guest Speaker, Santen Uveitis Update, Boston, Massachusetts, August 2015.

211. Guest Speaker, Discovery on Target, Boston, Massachusetts, September 2015.

212. Guest Speaker, 47th Annual Sally Letson Symposium, Ottawa, Ontario, September 2015.

213. Guest Speaker, 14th Annual Downeast Ophthalmology Symposium, Bar Harbor, Maine, October 2015.

214. Guest Speaker, American Academy of Ophthalmology, Las Vegas, Nevada, November 2015.

215. J. Donald M. Gass Memorial Lecturer (The Eleventh Annual), American Academy of Ophthalmology, Las Vegas, Nevada, November 2015.

216. Guest Speaker, Ophthalmic Imaging 2016, Palm Beach, Florida, December 2015.

217. Guest Speaker, Hawaiian Eye Meeting 2016, Big Island, Hawaii, January 2016.

218. Guest Speaker, Diabetic Retinopathy 2016, Naples, Florida, April 2016.



The Eye Cancer Network is supported by The Eye Cancer Foundation.
Help support eye cancer research and education now »